###begin article-title 0
###xml 52 55 52 55 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PIP</italic>
###xml 70 75 <span type="species:ncbi:9606">Human</span>
A Functional and Regulatory Network Associated with PIP Expression in Human Breast Cancer
###end article-title 0
###begin p 1
Conceived and designed the experiments: MAD EE DPT SI. Performed the experiments: MAD SEM VB. Analyzed the data: MAD DPT SI. Contributed reagents/materials/analysis tools: EE RMS AC. Wrote the paper: MAD CA DPT SI.
###end p 1
###begin title 2
Background
###end title 2
###begin p 3
###xml 4 7 4 7 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PIP</italic>
###xml 215 218 215 218 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PIP</italic>
###xml 388 391 388 391 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PIP</italic>
###xml 492 495 492 495 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PIP</italic>
The PIP (prolactin-inducible protein) gene has been shown to be expressed in breast cancers, with contradictory results concerning its implication. As both the physiological role and the molecular pathways in which PIP is involved are poorly understood, we conducted combined gene expression profiling and network analysis studies on selected breast cancer cell lines presenting distinct PIP expression levels and hormonal receptor status, to explore the functional and regulatory network of PIP co-modulated genes.
###end p 3
###begin title 4
Principal Findings
###end title 4
###begin p 5
###xml 70 73 70 73 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PIP</italic>
###xml 365 368 365 368 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PIP</italic>
Microarray analysis allowed identification of genes co-modulated with PIP independently of modulations resulting from hormonal treatment or cell line heterogeneity. Relevant clusters of genes that can discriminate between [PIP+] and [PIP-] cells were identified. Functional and regulatory network analyses based on a knowledge database revealed a master network of PIP co-modulated genes, including many interconnecting oncogenes and tumor suppressor genes, half of which were detected as differentially expressed through high-precision measurements. The network identified appears associated with an inhibition of proliferation coupled with an increase of apoptosis and an enhancement of cell adhesion in breast cancer cell lines, and contains many genes with a STAT5 regulatory motif in their promoters.
###end p 5
###begin title 6
Conclusions
###end title 6
###begin p 7
###xml 84 87 84 87 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PIP</italic>
###xml 287 290 287 290 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PIP</italic>
Our global exploratory approach identified biological pathways modulated along with PIP expression, providing further support for its good prognostic value of disease-free survival in breast cancer. Moreover, our data pointed to the importance of a regulatory subnetwork associated with PIP expression in which STAT5 appears as a potential transcriptional regulator.
###end p 7
###begin title 8
Introduction
###end title 8
###begin p 9
###xml 119 122 119 122 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004696-McPherson1">[1]</xref>
###xml 124 127 124 127 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004696-Harbeck1">[2]</xref>
###xml 499 502 487 490 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004696-Brenner1">[3]</xref>
###xml 899 902 887 890 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004696-Wells1">[4]</xref>
###xml 903 906 891 894 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004696-Fiel1">[7]</xref>
###xml 999 1002 987 990 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004696-Zagorianakou1">[8]</xref>
###xml 1003 1007 991 995 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004696-Park1">[12]</xref>
###xml 1082 1086 1070 1074 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004696-Murphy1">[13]</xref>
###xml 1088 1092 1076 1080 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004696-Clark1">[14]</xref>
###xml 158 166 <span type="species:ncbi:9606">patients</span>
Breast cancer is one of the most common malignancies in Western countries and is associated with a high mortality rate [1], [2]. Aside from a small subset of patients (approximately5%) with inherited genetic alterations, sporadic breast cancer accounts for the majority of all breast cancers and limited knowledge is available about the underlying process of carcinogenesis. It is widely accepted that breast cancer, like most other cancers, develops through the accumulation of genetic aberrations [3]. Some of these changes involve specific genetic loci, determining the activation of oncogenes or the inactivation of tumor-suppressor genes, while others confer genetic instability, which increases the possibility of acquiring additional genetic lesions relevant to tumorigenesis. In the last decades, PIP protein expression has been proposed as a specific and sensitive marker for breast cancer [4]-[7] and further used to support breast origin in metastatic carcinoma of unknown primary origin [8]-[12]. A PIP over-expression was shown in primary and metastatic breast cancers [13], [14], as well as in some breast carcinoma cell lines. However, the exact functions of that protein in mammary tumor progression remain unclear.
###end p 9
###begin p 10
###xml 163 167 163 167 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004696-Murphy1">[13]</xref>
###xml 222 226 222 226 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004696-Haagensen1">[15]</xref>
###xml 241 245 241 245 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004696-Autiero1">[16]</xref>
###xml 246 250 246 250 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004696-Basmaciogullari1">[18]</xref>
###xml 354 358 354 358 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004696-Gaubin1">[19]</xref>
###xml 421 425 421 425 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004696-Caputo1">[20]</xref>
###xml 444 447 444 447 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PIP</italic>
###xml 503 507 503 507 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004696-Lander1">[21]</xref>
###xml 582 586 582 586 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004696-Autiero3">[22]</xref>
###xml 588 592 588 592 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004696-Autiero4">[23]</xref>
###xml 677 680 677 680 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PIP</italic>
###xml 753 756 753 756 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PIP</italic>
###xml 871 875 871 875 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004696-Ciullo1">[24]</xref>
In previous work, we reported preliminary conclusions on the PIP properties showing that the protein, a secreted factor known as prolactin-inducible protein (PIP) [13] or as gross cystic disease fluid protein-15 (GCDFP-15)[15], binds to CD4 [16]-[18], exerts a potent inhibition on T lymphocyte apoptosis mediated by CD4/T-cell receptor (TCR) activation [19] and carries a fibronectin-specific aspartyl protease activity [20]. In addition, the PIP gene localized on the long arm of chromosome 7 at 7q34 [21] was found to display a variety of rearrangements in numerous solid tumors [22], [23]. Interestingly, we found that the T47D cell line, that constitutively overexpresses PIP, exhibits an inverted duplication of the 7q34-q35 region containing the PIP gene resulting from a breakage-fusion-bridge (BFB) cycle mechanism initiated within the common fragile site FRA7I [24].
###end p 10
###begin p 11
###xml 98 101 98 101 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PIP</italic>
###xml 286 289 286 289 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PIP</italic>
###xml 411 414 411 414 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PIP</italic>
###xml 459 462 459 462 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PIP</italic>
###xml 831 834 831 834 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PIP</italic>
###xml 1277 1280 1277 1280 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PIP</italic>
Here, we report an in-depth exploration of the functional and regulatory networks associated with PIP gene expression in breast carcinoma cell lines using DNA microarray-based gene expression profiling techniques. Taking advantage of the presence of androgen-responsive elements in the PIP gene promoter, breast carcinoma cell lines were analyzed before and after treatment with dihydrotestosterone to modulate PIP expression, allowing comparison between the PIP-expressing [PIP+] and -non expressing [PIP-] cell profiles. Thus, we identified a series of 205 genes that display significant expression changes between the [PIP+] and [PIP-] subgroups of samples. A representative part of these genes exhibited a good concordance of expression changes when assessed using tailored Q-PCR. A network analysis allowed us to propose that PIP gene expression is mainly associated with a decrease of the cell proliferation and migration potential, as well as with an increase of the apoptotic pathway. In addition, the identification of specific STAT5 (Signal Transducer and Activator of Transcription 5) motifs found within promoters of a significant part of the differentially expressed genes suggests that STAT5 could play an important role in the regulatory network associated with PIP expression. We also point to other novel modulated pathways that warrant further biological and clinical investigations.
###end p 11
###begin title 12
Results and Discussion
###end title 12
###begin title 13
Characterization of the cellular models
###end title 13
###begin p 14
###xml 82 85 82 85 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PIP</italic>
###xml 331 335 331 335 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004696-Thompson1">[25]</xref>
Four breast cancer cell lines presenting different features especially concerning PIP expression, hormonal receptor status and invasiveness potential were selected: MDA-MB231, a poorly differentiated and highly invasive cell line, MCF7, T47D and VHB1, which are known to be differentiated and non-invasive breast cancer cell lines [25].
###end p 14
###begin p 15
###xml 3 6 3 6 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PIP</italic>
###xml 57 61 57 61 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004696-Loos1">[26]</xref>
###xml 122 124 122 124 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">AR</italic>
###xml 163 165 163 165 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ER</italic>
###xml 355 359 355 359 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004696-Sorlie1">[27]</xref>
###xml 361 365 361 365 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004696-Simard1">[28]</xref>
###xml 464 466 464 466 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">AR</italic>
###xml 664 666 664 666 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ER</italic>
###xml 855 862 855 862 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="pone-0004696-t001">Table 1</xref>
As PIP expression was shown to be increased by androgens [26], we first analyzed the expression of the androgen receptor (AR). Moreover, as the estrogen receptor (ER) expression is currently used as a potential marker to classify breast cancer samples, and the ER-positive tumors are often found associated with a better outcome than the ER-negative ones [27], [28], we also analyzed the status of this hormonal receptor in the four cell lines. RT-PCR analysis of AR expression in the four cell lines indicated that MDA-MB231 is AR-negative and MCF7 AR-positive (data not shown). As expected both T47D and VHB1 cells were AR-positive. Similarly, the expression of ER was found positive in MCF7, T47D and VHB1 and negative in MDA-MB231. The phenotype of the cell lines further used for DNA microarray-based gene expression profile studies is summarized in Table 1.
###end p 15
###begin title 16
PIP and hormonal receptor status in breast cancer cell lines.
###end title 16
###begin p 17
###xml 23 26 23 26 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PIP</italic>
###xml 47 49 47 49 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">AR</italic>
###xml 74 76 74 76 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ER</italic>
###xml 120 123 120 123 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PIP</italic>
Relative expression of PIP, androgen receptor (AR) and estrogen receptor (ER) assessed by RT-PCR in each cell line. The PIP expression was determined with or without DHT treatment. The cell lines were classified in 3 distinct categories, corresponding to no (-) expression or a basal (+) or a high (++) level of expression for each gene, respectively.
###end p 17
###begin p 18
###xml 40 43 40 43 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PIP</italic>
###xml 178 181 178 181 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PIP</italic>
###xml 229 237 229 237 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0004696-g001">Figure 1</xref>
###xml 254 257 254 257 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PIP</italic>
###xml 313 315 313 315 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">AR</italic>
###xml 471 474 471 474 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PIP</italic>
###xml 521 524 521 524 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PIP</italic>
###xml 684 687 684 687 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PIP</italic>
###xml 706 709 706 709 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PIP</italic>
###xml 796 804 796 804 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0004696-g001">Figure 1</xref>
###xml 1121 1124 1121 1124 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PIP</italic>
###xml 789 794 <span type="species:ncbi:9606">women</span>
Androgen treatments were used to induce PIP expression. Breast cancer cell lines were grown in presence or absence of 10 nM of dihydrotestosterone (DHT) for various periods, and PIP gene expression was analyzed by northern blot (Figure 1). No detectable PIP expression was found in MCF7 despite the expression of AR; similar results were obtained in MDA-MB231 even after 10 days of androgen treatment (data not shown). In contrast, in T47D which constitutively expresses PIP, DHT treatment for 6, 8 and 10 days increased PIP expression about 2.5, 4 and 4.9 times, respectively, whereas in VHB1 that did not exhibit detectable endogenous expression, DHT treatment induced a consistent PIP expression. A low PIP expression level was observed in mammary gland samples (MG) taken from healthy women (Figure 1). Identical phenotypes were observed by RT-PCR (data not shown). In the present study, our strategy was to take advantage of the differences in hormonal receptor expression level and invasiveness potential of the distinct cell lines in order to predominantly focus on the gene expression modulations associated with PIP expression, but independently of the possible influence of particular genetic backgrounds. Thus, the samples were categorized in either a [PIP+] or a [PIP-] subgroup and used for subsequent analyses.
###end p 18
###begin title 19
###xml 0 3 0 3 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PIP</italic>
PIP expression analysis after DHT treatment in breast carcinoma cell lines and normal mammary gland.
###end title 19
###begin p 20
Relative abundance of PIP mRNA was assessed by Northern Blot analysis (upper panels). Total RNAs were extracted from normal mammary gland (MG, 15 microg) and from three breast carcinoma cell lines (MCF7, T47D and VHB1, 50 microg), at several days (0, 6, 8 and 10 days) after DHT treatment. The relative beta-actin expression levels in each sample are shown (lower panels).
###end p 20
###begin title 21
Experimental design and statistical power simulations
###end title 21
###begin p 22
Gene expression profiles were collected in duplicate from a total of 32 RNA samples derived from 4 independent cultures and RNA preparations of the 4 breast carcinoma cell lines cultured without (J0) and with DHT for 7 days (J7).
###end p 22
###begin p 23
The a priori statistical power of the gene expression dataset was measured as the probability of obtaining statistical significance when true biological differences exist between the compared groups of samples (1 - beta; true positive rate). A conventional power analysis requires the designation of parameters such as the anticipated variability of individual measurements for all genes within each biological group (sigma), the total sample size (n, n1 & n2), the magnitude of the effect to be detected (Phi) and the acceptable false positive rate (significance level alpha). It allows verifying which subgroups of samples are likely to provide the most comprehensive relevant information and that enough samples are compared to meet the objectives of the study.
###end p 23
###begin p 24
###xml 61 64 61 64 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PIP</italic>
###xml 83 90 83 90 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="pone-0004696-t001">Table 1</xref>
###xml 399 402 399 402 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PIP</italic>
###xml 522 530 522 530 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0004696-g001">Figure 1</xref>
Thus, samples were divided in 2 subgroups according to their PIP expression level (Table 1). MDA-MB231 (J0 and J7), MCF7 (J0 and J7) and VHB1 (J0) samples were considered as [PIP-] and all others as [PIP+] samples. Some additional analyses were conducted using 3 phenotype classes [PIP-], [PIP+] and [PIP++] instead of 2. In this case, the [PIP++] subgroup contained T47D (J0 and J7) samples as the PIP expression level is significantly higher than in VHB1 (J7) and can influence differently the gene expression profiles (Figure 1).
###end p 24
###begin p 25
###xml 319 326 312 319 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="pone-0004696-t002">Table 2</xref>
###xml 398 404 387 393 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">median</sub>
###xml 537 544 523 530 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="pone-0004696-t002">Table 2</xref>
###xml 613 620 599 606 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="pone-0004696-t003">Table 3</xref>
Statistical power (1-beta) was computed for a two-class comparison, detecting a true 1.5-fold mean difference between either the [PIP+] or [PIP++] group of samples and the [PIP-] group of samples at a significance level (alpha) of 0.01, considering a total sample size of 64 or 56 respectively with n2/n1 = 0.6 or 0.4 (Table 2), and an expected variability within each biological sample group sigmamedian< = 0.30. The statistical power was estimated to be satisfactory, with a limited proportion of false negatives (beta = 0.01 to 0.03, Table 2), while consistent with a small number of spurious discoveries (cf. Table 3).
###end p 25
###begin title 26
Statistical power simulations of the gene expression dataset.
###end title 26
###begin p 27
###xml 198 217 197 216 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="sec" rid="s3">Materials &amp; Methods</xref>
The statistical power (Z; 1- ss) is the probability of obtaining statistical significance in comparing gene expression. Simulations for unpaired two-class comparison statistics are described in the Materials & Methods. Calculation includes the following parameters:
###end p 27
###begin p 28
- a significance level (alpha) of 0.01.
###end p 28
###begin p 29
- the observed biological variability (sigma).
###end p 29
###begin p 30
- a sample size (n) from individual [PIP++], [PIP+] and [PIP-] samples.
###end p 30
###begin p 31
- a true difference (i.e. 1.2, 1.35, 1.5 or 1.8) in mean expression ratios between the respective classes.
###end p 31
###begin title 32
False discovery rate of the gene expression dataset.
###end title 32
###begin p 33
Expected False discovery rates (FDR) that may be anticipated from a gene expression comparisons from the [PIP++], [PIP+] and [PIP-] subgroups of samples.
###end p 33
###begin p 34
The simulations thus suggested that only a negligible proportion of the information relevant to the question addressed would be missed in the class comparisons, and provided a high confidence toward the differentially expressed genes identified.
###end p 34
###begin title 35
Measure of the range of biological variability in samples
###end title 35
###begin p 36
###xml 81 84 81 84 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PIP</italic>
###xml 225 233 225 233 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0004696-g002">Figure 2</xref>
###xml 430 433 430 433 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PIP</italic>
###xml 602 610 602 610 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0004696-g002">Figure 2</xref>
###xml 964 967 964 967 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PIP</italic>
###xml 1324 1327 1324 1327 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PIP</italic>
As the cell line intrinsic properties may obscure expression patterns related to PIP gene expression, we appreciated the range of biological variability through unsupervised clustering of the entire gene expression profiles (Figure 2). Similarity measures between genes were computed using a Pearson correlation. Clusters were defined by an average linkage clustering method. No clear cluster was observed according to either the PIP gene expression level or the ER status, the resulting dendrograms of the samples probably reflecting predictable biological variability between cell lines. As shown in Figure 2, samples were clustered in two distinct groups, one containing DHT-untreated (J0) or -treated (J7) MDA-MB231 and VHB1 J7 samples, the other MCF7 (J0 and J7), VHB1 J0, T47D (J0 and J7) and normal mammary gland samples. Except for the VHB1 samples, serially treated cell line samples tended mainly to cluster together, independently from DHT treatment or PIP expression. This indicates that the genome-wide expression profile changes induced by the hormonal treatment may be less prominent than the inherent observed cell line differences. The transcriptome data analysis strategy was therefore designed to assess the likelihood of detecting reliably significant gene expression differences linked to variations in PIP expression.
###end p 36
###begin title 37
Range of biological variability of the gene expression dataset.
###end title 37
###begin p 38
Similarity dendrograms (Pearson correlation) resulting from unsupervised hierarchical clustering of DHT-treated (J7) or -untreated (J0) breast carcinoma cells based on the global gene expression matrix. [PIP+] and [PIP-] cells are indicated in red and blue, respectively.
###end p 38
###begin title 39
###xml 46 49 46 49 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PIP</italic>
Identification of the genes co-modulated with PIP expression
###end title 39
###begin p 40
###xml 147 150 147 150 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PIP</italic>
###xml 803 806 803 806 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PIP</italic>
###xml 993 996 993 996 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PIP</italic>
###xml 1178 1179 1178 1179 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">t</italic>
###xml 1185 1186 1185 1186 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">F</italic>
###xml 1246 1254 1246 1254 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pone.0004696.s001">Table S1</xref>
###xml 1371 1379 1371 1379 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pone.0004696.s002">Table S2</xref>
###xml 1655 1658 1655 1658 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PIP</italic>
###xml 1698 1701 1698 1701 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PIP</italic>
###xml 2108 2111 2108 2111 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PIP</italic>
Beforehand, several statistical differential comparisons were performed to first highlight gene expression modulation that may be unrelated to the PIP gene influence, but potentially resulting from the cell line heterogeneity itself. The analysis was done comparing the expression profiles of the 3 cell lines associated with a [PIP-] phenotype (i.e. MCF7, VHB1 and MDA-MB231) without DHT treatment in order to identify specific unique gene expression. This analysis pointed out 85% of the genes (7,996 clones) that were found not significantly differentially expressed between the 3 cell lines (p = 0.01). The corresponding gene list was used as a reference for subsequent statistical analyses with the drawback that a fraction of them will escape detection of differential expression in relation with PIP in subsequent analyses, being confounded by differences in the genetic background of the individual cell lines, but ensuring that the gene modulations identified are strictly related to PIP expression. Two- and three-class comparisons of mean relative expression levels were then performed gene-by-gene between [PIP++], [PIP+] and [PIP-] subgroups using a combination of t- and F- statistic approaches and yielded complementary lists (See Table S1), including a list of 606 clones (L606, two-class, data not shown) and a list of 235 clones (L235, three-class, see Table S2). The 3-class comparison was privileged to take into account the additional modulations of expression that could occur between samples with a moderate [PIP+] or a high [PIP++] expression and to focus our exploration on genes that may be found co-regulated in relation to the PIP expression level changes. The split of PIP-expressing samples in two separate subgroups of samples raised the strength of the statistical analysis and led to the identification of a more extensive and explicit list of modulated genes, as 44% of the clones in L235 were not detected in two-class comparison and therefore not included in L606. In addition, these genes are unlikely to correspond to genes modulated by DHT treatment independently from PIP expression, since both [PIP+] and [PIP++] subgroups of samples consist of treated samples and the [PIP++] subgroup contains a balanced number of treated and untreated samples.
###end p 40
###begin p 41
###xml 87 91 87 91 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004696-httpgenomewww5.stanford.educgibinsourcesourceSearch1">[29]</xref>
###xml 166 174 166 174 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pone.0004696.s002">Table S2</xref>
###xml 857 864 857 864 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="pone-0004696-t001">Table 1</xref>
###xml 867 874 867 874 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="pone-0004696-t002">Table 2</xref>
###xml 1003 1010 1003 1010 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="pone-0004696-t003">Table 3</xref>
The genes represented in L235 were annotated using the Unigene Cluster Ids identifiers [29]. L235 corresponds to 205 unique genes (193 unique named genes) (L235; see Table S2), including 92 up-regulated named genes (64%) and 51 down-regulated named genes in the [PIP+] group when compared with the [PIP-] group, with a fold-change over 1.35. More than one third of the selected genes were associated with a fold-change ranging from 1.35 to 1.5; thus, the effective statistical power was computed to evaluate the reliability of detection of such slight gene modulations for both two- and three-class comparisons. We found the computed power to be satisfactory, being over 90% and 78%, thereby ensuring the reliable detection of these small variations in gene expression between [PIP+] and [PIP-] samples and between [PIP++] and [PIP-] samples, respectively (Table 1 & Table 2). The false positive rate associated with this threshold ratio was estimated to be lower than 0.2% in all subgroup comparisons (Table 3), confirming that these slightly modulated genes could be taken into account confidently.
###end p 41
###begin p 42
###xml 214 222 214 222 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0004696-g003">Figure 3</xref>
###xml 464 467 464 467 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PIP</italic>
###xml 615 623 615 623 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0004696-g002">Figure 2</xref>
###xml 750 751 750 751 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">t</italic>
###xml 1016 1017 1012 1013 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">t</italic>
###xml 1042 1044 1038 1040 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;4</sup>
###xml 1279 1280 1275 1276 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">t</italic>
###xml 1318 1320 1314 1316 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;4</sup>
###xml 1329 1331 1325 1327 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;2</sup>
###xml 1334 1342 1330 1338 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0004696-g003">Figure 3</xref>
To further probe the ability of different subsets of the genes represented in L235 to discriminate between [PIP+] and [PIP-] phenotypes, supervised hierarchical clustering of the expression profiles was performed (Figure 3). Gene clusters with related expression patterns were clearly discernable, consistently pointing out differences between the PIP-expressing and non-expressing samples. Precisely, the samples are divided in two main groups according to their PIP expression phenotype. This observation contrasts with the sample similarity dendrogram previously obtained using the whole gene expression matrix (Figure 2). Clusters of gene modules that appeared the most relevant to differentiate [PIP+] and [PIP-] subgroups were identified using t-statistics with a permutation-based adjustment of the gene expression matrix (n = 10,000 and alpha = 0.05). The top-ranked clusters were NODE222X of 60 clones (50 named genes and 7 not assigned to any Unigene cluster Id) found up-regulated in the [PIP+] subgroup (t-stat = -4.57; p = 2.5x10-4) and NODE196X and NODE167X containing 26 and 11 clones (23 and 8 named genes, respectively, and 3 not assigned to any Unigene cluster Id in each node), which conversely represent clusters of genes up-regulated in the [PIP-] subgroup (t-stat = 4.16 and 2.89 and ; p = 8.7x10-4 and 2x10-2) (Figure 3).
###end p 42
###begin title 43
Hierarchical clustering of the differentially expressed genes.
###end title 43
###begin p 44
###xml 191 194 191 194 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PIP</italic>
###xml 480 481 480 481 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">t</italic>
###xml 603 606 599 602 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PIP</italic>
Unsupervised hierarchical clustering of all samples for the genes found significantly differentially expressed (L235) between [PIP+] and [PIP-] phenotypes, and modulated in relation with the PIP expression. Genes (row) and samples (columns) are clustered independently using uncentered Pearson correlation metrics. [PIP+] and [PIP-] cell lines are indicated in red and green, respectively. The top-ranked relevant gene clusters (NODE 167X, NODE 196X and NODE 222X) selected using t-statistics with permutation-based adjustment (n = 10,000; alpha = 0.05) are indicated by color bars. The presence of the PIP gene is pointed.
###end p 44
###begin title 45
Validation of the microarray gene expression data
###end title 45
###begin p 46
###xml 204 217 204 209 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;&#916;&#916;Ct</sup>
###xml 219 223 211 215 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004696-Livak1">[30]</xref>
###xml 313 317 305 309 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PPIA</italic>
The accuracy and reliability of the results obtained with microarrays was tested by quantitative RT-PCR (Q-PCR) using a tailored TaqMan Low Density Array (LDA). The relative gene expression levels (RQ = 2-DeltaDeltaCt, [30]) in [PIP+] and [PIP-] samples were normalized to that of the peptidylprolyl isomerase A (PPIA) housekeeping gene and relative to the median value of all samples taken as calibrator reference. The data are expressed as the RQ ratios in [PIP+] versus [PIP-] samples.
###end p 46
###begin p 47
###xml 70 78 70 78 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pone.0004696.s001">Table S1</xref>
###xml 225 232 225 232 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="pone-0004696-t004">Table 4</xref>
###xml 453 460 453 460 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="pone-0004696-t005">Table 5</xref>
###xml 1007 1014 1007 1014 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="pone-0004696-t005">Table 5</xref>
Thirty-two genes (28 from list L235, 4 from lists L578 and L2231, see Table S1) were chosen for validation of microarray data. Nine additional genes were selected among those found not significantly differentially expressed (Table 4). Comparison of microarray and Q-PCR results after z-statistics with FDR adjustments indicated a good agreement: 28 of the 32 (87%) differentially expressed genes detected with microarrays were fully validated by Q-PCR (Table 5). The remaining differentially expressed genes were considered as false positive results: two of them were associated with an inverted Q-PCR expression ratio compared to that obtained with microarrays and the 2 others were not found significantly differentially expressed when analyzed by Q-PCR. Finally, four of the nine genes not detected as differentially expressed with microarrays and found discordant when analyzed by Q-PCR are likely to represent microarray false negative results or false positive results of one or the other technology (Table 5).
###end p 47
###begin title 48
Descriptive list of the genes selected for biological validation by quantitative RT-PCR (Q-PCR).
###end title 48
###begin p 49
###xml 586 587 582 583 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 686 687 678 679 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 702 703 694 695 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 741 742 733 734 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
Thirty-two genes found differentially expressed (displayed in bold) and 9 additional genes with no significant differential expression (displayed in italics) using microarrays (alpha = 0.01) were selected for further biological validation. For each gene symbol, clone ID and median intensity values (displayed in arbitrary unit) of [PIP+] and [PIP-] cell lines are indicated. The relative expression levels recorded with microarrays are displayed as the ratio between [PIP+] and [PIP-] samples, and the values specified as negative (down-regulated) or positive (up-regulated). Adjusted p values were computed using z statistics with false discovery rate corrections (alpha = 0.05). Min p value and Max p value refer to lower and upper bound p values, respectively.
###end p 49
###begin p 50
###xml 48 52 48 52 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">BCL2</italic>
###xml 54 57 54 57 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MYC</italic>
###xml 60 68 60 68 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pone.0004696.s001">Table S1</xref>
###xml 81 85 81 85 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">BCL2</italic>
###xml 87 93 87 93 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CDKN1A</italic>
###xml 95 101 95 101 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">COL6A2</italic>
###xml 103 106 103 106 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MYC</italic>
###xml 113 121 113 121 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pone.0004696.s001">Table S1</xref>
Differentially expressed genes from lists L578 (BCL2, MYC) (Table S1) and L2231 (BCL2, CDKN1A, COL6A2, MYC) (See Table S1).
###end p 50
###begin title 51
Q-PCR validation of the expression of the 41 selected genes in cell lines.
###end title 51
###begin p 52
###xml 41 57 41 57 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="sec" rid="s3">Material&amp;Methods</xref>
###xml 672 673 672 673 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
Q-PCR analysis was done according to the Material&Methods on the same samples set used in microarray analysis. Gene symbol and TaqMan assay (assay ID) are indicated. The genes that were found differentially expressed (L235) or not significantly modulated using microarray are displayed in bold and italics, respectively, and classified as fully validated genes or potential false discoveries considering the Q-PCR results. The Ct values correspond to the median of threshold cycles of [PIP+] and [PIP-] samples. The expression changes (ratio) between the [PIP+] and the [PIP-] samples are specified as negative (down-regulated) or positive (up-regulated) values. Adjusted p-values were computed using z statistics with false discovery rate corrections (alpha = 0.05).
###end p 52
###begin p 53
###xml 275 278 275 278 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PIP</italic>
Taken together, these results show that most of the genes identified by microarrays were validated and only few genes were found to be false positive results. Thus, expression of the genes in L235 derived from the three-class comparison correlates directly or inversely with PIP modulations. It provides a faithful representation of the breast cancer cellular model and therefore a solid basis for further functional exploration of the results.
###end p 53
###begin title 54
Functional annotation of the differentially expressed genes
###end title 54
###begin p 55
###xml 471 478 471 478 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="pone-0004696-t006">Table 6</xref>
###xml 485 486 485 486 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 946 947 942 943 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 989 996 985 992 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="pone-0004696-t006">Table 6</xref>
Functional analysis was performed using the Ingenuity Pathway Analysis (IPA, version 4.0) tool which relies on a knowledge database of curated functional and regulatory interactions extracted from the literature and provides integrated graphical representation of the biological relationships between genes and gene products. Two distinct analyses were performed based on Locuslink ID gene identifiers, considering separately up- and down-regulated genes from list L235 (Table 6). The p-values relative to the most enriched functions appeared highly significant (alpha = 0.05, Fisher's exact test). A total of 48 and 43 significantly over-represented biological functions were identified in the up- and down-regulated gene lists, respectively. Among them, 37 are overlapping. The significance was higher for functions associated with down-regulated genes. The 20 most relevant functions identified with down-regulated genes and the corresponding p-values for both analyses are reported in Table 6.
###end p 55
###begin title 56
###xml 23 26 23 26 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PIP</italic>
Functional analysis of PIP co-modulated genes.
###end title 56
###begin p 57
###xml 220 221 220 221 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 282 283 282 283 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 789 790 785 786 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 904 905 900 901 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 939 940 935 936 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
List of the statistically relevant top twenty of over-represented biological functions. Distinct analyses were performed using the IPA tool (version 4.0) for up- and down-regulated genes. For each function, the computed p-values are reported as well as the total number of genes. A p-value for a given process is computed using a one-side right-tailed Fisher exact test (alpha = 0.05) by considering the total number of up- or down-regulated genes from L235 and the number of genes that are known to be associated with that process in the IPA knowledge base. As a function may be divided in several sub-functions (for instance, the functions interphase, S phase and G1 phase and G0/G1 phase refer to the unique cell cycle function), the statistical results are displayed as an interval of p-values reflecting the range computed for each sub-function. The biological processes are ranked according to the p-value of up-regulated genes. The p-value appear in bold if the upper limit of the interval is lower than 1e-10.
###end p 57
###begin p 58
###xml 191 192 191 192 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 294 297 294 297 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PIP</italic>
###xml 963 970 963 970 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="pone-0004696-t006">Table 6</xref>
###xml 1103 1104 1103 1104 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 1161 1162 1161 1162 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
Thus, cancer, cell cycle, cellular growth and proliferation related functions appeared to be in the top five of highest-level functions highlighted in both analyses according to the assigned p-value. Cell death was also associated with significant expression changes in genes co-modulated with PIP (1.33e-10 to 9.72e-5 for up-regulated genes and 1.96e-12 to 3.58e-7 for down-regulated genes). Taken together, these results suggest that tumor proliferation might be deeply impacted by modulations of gene expression levels between the [PIP+] and the [PIP-] samples. Moreover, significantly enriched gene classes related to down-regulated genes in [PIP+] versus [PIP-] samples are highly indicative of processes involving cell morphology and movement. The prominent functions associated with theses classes are cell morphology, tissue morphology, tumor morphology, cellular movement, cell to cell signalling and interaction, and cellular assembly and organization (Table 6). These biological functions are also found significantly over-represented in the up-regulated gene list even though the associated p-values are slightly smaller but statistically relevant (p-value lower limit</=1e-6). A large number of genes involved in cellular movement partly overlapped with cancer-related genes. Altogether these gene expression modulations might influence cell death or tumor invasiveness.
###end p 58
###begin title 59
###xml 53 56 53 56 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PIP</italic>
Identification of molecular networks associated with PIP gene expression modulations
###end title 59
###begin p 60
###xml 1192 1199 1192 1199 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="pone-0004696-t007">Table 7</xref>
We next investigated biological relationships between genes and gene products by performing a network analysis for the genes represented in L235. A total of 126 unique genes in L235, called focus genes, were mapped to genetic networks as defined by the IPA tool. Nine networks were found significantly enriched with scores ranging from 9 to 19 (data not shown), the probability for a network to be selected by chance (score<3) decreasing when its corresponding score value increases. As network identification using the IPA tool may be strongly dependent upon size and content of the input gene list used, further analyses were conducted using independent gene lists for the up- and down-regulated genes in L235. This analysis led to the identification of ten and eleven networks for up- and down-regulated genes, respectively (data not shown). These networks were associated with the same biological functions (i.e. cancer, cell death, cell cycle, cellular growth, gene expression, proliferation and tissue morphology) exhibiting higher scores (15-23 and 8-23 for the top 6 up- and 4 down-regulated gene networks, respectively) as those previously identified using the whole gene list L235 (Table 7).
###end p 60
###begin title 61
Global network analysis of differentially expressed genes.
###end title 61
###begin p 62
Up- and down-regulated genes from L235 analyzed using the IPA tool (version 4.0). Among them 74 up- and 52 down-regulated genes were eligible for generating networks and led to the identification respectively of 10 and 11 distinct networks containing both direct and indirect interactions scored by significance. The six up and four down-regulated networks considered as relevant (i.e. score>3) are reported. Genes selected as differentially expressed in [PIP+] versus [PIP-] samples (i.e. Focus genes) are shown in bold. Underlined genes indicate those belonging to multiple networks. The other genes are either absent from the microarray or found not significantly regulated.
###end p 62
###begin p 63
###xml 108 111 108 111 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">BAD</italic>
###xml 113 119 113 119 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CDKN2A</italic>
###xml 121 126 121 126 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PRAME</italic>
###xml 128 132 128 132 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004696-Chao1">[31]</xref>
###xml 133 137 133 137 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004696-Campbell1">[33]</xref>
###xml 190 195 190 195 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CCND3</italic>
###xml 197 203 197 203 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CDKN2A</italic>
###xml 205 210 205 210 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">EFNA1</italic>
###xml 212 218 212 218 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">HRASL3</italic>
###xml 223 228 223 228 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PRAME</italic>
###xml 229 233 229 233 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004696-Sers1">[34]</xref>
###xml 234 238 234 238 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004696-Parri1">[39]</xref>
###xml 297 301 297 301 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ARD1</italic>
###xml 303 307 303 307 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CTPS</italic>
###xml 309 315 309 315 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">EEF1B2</italic>
###xml 317 322 317 322 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">LOXL2</italic>
###xml 324 328 324 328 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">NRAS</italic>
###xml 333 336 333 336 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PTN</italic>
###xml 373 377 373 377 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004696-Cho1">[40]</xref>
###xml 378 382 378 382 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004696-Garbay1">[47]</xref>
###xml 415 420 415 420 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MMP14</italic>
###xml 425 430 425 430 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">HDAC3</italic>
###xml 533 538 533 538 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MMP14</italic>
###xml 609 613 609 613 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004696-Tetu1">[48]</xref>
###xml 618 623 618 623 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">HDAC3</italic>
###xml 689 693 689 693 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004696-Huang1">[49]</xref>
###xml 695 699 695 699 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004696-Glaser1">[50]</xref>
###xml 814 818 814 818 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">BAG1</italic>
###xml 820 824 820 824 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CTSL</italic>
###xml 826 830 826 830 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CTPS</italic>
###xml 832 835 832 835 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PTN</italic>
###xml 837 842 837 842 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">LOXL2</italic>
###xml 844 848 844 848 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004696-Peinado1">[44]</xref>
###xml 850 854 850 854 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004696-Bowden1">[51]</xref>
###xml 855 859 855 859 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004696-Tobin1">[54]</xref>
###xml 919 924 919 924 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">BNIP2</italic>
###xml 980 984 980 984 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004696-Qin1">[55]</xref>
Among the selected networks, several up-regulated genes are found associated with a pro-apoptotic function (BAD, CDKN2A, PRAME) [31]-[33] and an inhibition of cell growth and proliferation (CCND3, CDKN2A, EFNA1, HRASL3 and PRAME)[34]-[39]. These results are concordant with the down-regulation of ARD1, CTPS, EEF1B2, LOXL2, NRAS and PTN known to promote cell proliferation [40]-[47]. Only two over-expressed genes, MMP14 and HDAC3, could result in possible conflicting functions leading to enhanced cell proliferation. For instance, MMP14 was previously shown to enhance proliferation in many types of tumors [48] and HDAC3 silencing demonstrated to induce cell cycle arrest and apoptosis [49], [50]. Conversely, most down-regulated genes involved in the cell death pathway are linked to anti-apoptotic functions (BAG1, CTSL, CTPS, PTN, LOXL2) [44], [51]-[54]. Nevertheless, decrease of expression of the pro-apoptotic BNIP2 gene could support an opposite effect on cell survival [55].
###end p 63
###begin p 64
###xml 63 67 63 67 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CD82</italic>
###xml 69 74 69 74 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">EFNA1</italic>
###xml 76 81 76 81 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ITGB6</italic>
###xml 83 89 83 89 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">LGALS8</italic>
###xml 136 139 136 139 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PIP</italic>
###xml 139 143 139 143 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004696-Yang1">[56]</xref>
###xml 144 148 144 148 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004696-Mogi1">[61]</xref>
###xml 188 194 188 194 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PEA-15</italic>
###xml 345 349 345 349 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004696-Glading1">[62]</xref>
###xml 379 385 379 385 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PEA-15</italic>
###xml 537 543 537 543 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PEA-15</italic>
###xml 745 750 745 750 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">FXYD5</italic>
###xml 752 757 752 757 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ICAM1</italic>
###xml 762 767 762 767 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MMP14</italic>
###xml 812 816 812 816 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004696-Mylona1">[63]</xref>
###xml 817 821 817 821 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004696-Nam1">[66]</xref>
###xml 1177 1184 1177 1184 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vivo</italic>
###xml 1361 1365 1361 1365 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004696-Sandberg1">[67]</xref>
The expression level of genes implicated in cellular adhesion (CD82, EFNA1, ITGB6, LGALS8) is found increased in samples overexpressing PIP[56]-[61]. In addition, an overexpression of the PEA-15 gene is observed in the [PIP+] versus the [PIP-] samples. The PEA-15 function was recently related to cell invasion via its ability to bind to ERK1/2 [62]. It has also been shown that PEA-15 is expressed in normal mammary gland and exhibits a decreased expression in pathologically invasive cancer, suggesting an inverse relationship between PEA-15 expression and tumor invasion. All considered, observed up-regulations could reinforce cell adhesion and consequently exert a preventive effect on cell motility and metastasis development. Conversely, FXYD5, ICAM1 and MMP14 overexpression might enhance tumor invasion [63]-[66]. In fact, several studies on breast cancer samples have shown a major role of the protease MMP14 in the invasion process occurring mainly via extracellular matrix remodelling. These discordant observations may reflect differences in gene expression observed between tumor and cell line models resulting from the environmental specificities of tumor cells in vivo and the heterogeneous mixture of cells in tumor samples, including immune cells as well as tissue-specific cells, which cannot be reproduced with cells grown in culture plates [67].
###end p 64
###begin p 65
###xml 241 248 241 248 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="pone-0004696-t007">Table 7</xref>
###xml 344 350 344 350 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">IQGAP1</italic>
###xml 352 357 352 357 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TGFBI</italic>
###xml 359 363 359 363 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CD44</italic>
###xml 365 369 365 369 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CTSL</italic>
###xml 371 374 371 374 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PTN</italic>
###xml 376 380 376 380 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004696-Lyzak1">[68]</xref>
###xml 381 385 381 385 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004696-Niedergethmann1">[71]</xref>
###xml 548 553 548 553 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">LOXL2</italic>
###xml 712 716 712 716 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004696-Peinado1">[44]</xref>
The down-regulated gene analysis also highlighted a network linked to cell to cell signalling and cellular movement function, reflecting an impact of these gene modulations on cell motility and invasiveness (network 8, down-regulated genes, Table 7). Within this network, several genes had a function promoting migration and cell invasiveness (IQGAP1, TGFBI, CD44, CTSL, PTN) [68]-[71]. Accordingly, their down-regulation in [PIP+] versus [PIP-] samples could have a suppressive effect on cell invasion. Similarly, the down-regulated expression of LOXL2 might prevent tumor progression, as shown by the induction of the epithelial-to-mesenchymal transition process in epithelial cells overexpressing these genes [44].
###end p 65
###begin p 66
In summary, this pathway analysis strongly suggests that the majority of gene modulations, occurring in [PIP+] versus [PIP-] cells, may contribute to a reduction of cell proliferation concomitantly with an increase of apoptosis and cell adhesion.
###end p 66
###begin title 67
Visualization of relevant modulations in a master molecular interaction network
###end title 67
###begin p 68
###xml 239 247 239 247 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0004696-g004">Figure 4</xref>
###xml 455 458 455 458 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PIP</italic>
###xml 479 486 479 486 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="pone-0004696-t007">Table 7</xref>
###xml 547 551 547 551 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CD14</italic>
###xml 556 560 556 560 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TCF3</italic>
###xml 581 586 581 586 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CCND3</italic>
###xml 747 748 747 748 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">t</italic>
###xml 993 997 993 997 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TP53</italic>
###xml 1020 1026 1020 1026 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">IQGAP1</italic>
###xml 1047 1054 1047 1054 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="pone-0004696-t007">Table 7</xref>
In order to visualize comprehensive interactions between the modulated genes within breast cancer cells and place them in the context of molecular interaction network, the most significant up- and down-regulated gene networks were merged (Figure 4). Networks 1, 4 and 6 of up-regulated genes were chosen according to the highest score value (23), the corresponding functions in tumorigenesis (proliferation, cancer and cell cycle) and the presence of the PIP gene, respectively (Table 7). These networks were merged through the overlapping genes (CD14 and TCF3 for networks 1 & 6; CCND3 for networks 4 & 6). About 45% of the focus genes of those up-regulated gene networks are found to take part in one of the most relevant clusters identified by t-statistics in L235 hierarchical clustering. More specifically, 67% of the focus genes from network 1 are included in NODE 222X. Networks 7, 8 and 10 of down-regulated genes were selected upon the presence of overlapping genes between networks: TP53 for networks 7&10 and IQGAP1 for networks 7 & 8 (Table 7). An important fraction of the focus genes from those down-regulated gene networks are localized within NODE 167X or NODE 196X from L235 hierarchical clustering.
###end p 68
###begin title 69
###xml 52 55 52 55 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PIP</italic>
Master molecular network of genes co-modulated with PIP.
###end title 69
###begin p 70
###xml 189 196 189 196 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="pone-0004696-t007">Table 7</xref>
###xml 460 463 460 463 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PIP</italic>
###xml 465 469 465 469 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">EGR2</italic>
###xml 474 477 474 477 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CD4</italic>
###xml 809 812 809 812 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PIP</italic>
###xml 1231 1239 1231 1239 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pone.0004696.s001">Table S1</xref>
Master network assembled by merging networks 1, 4 & 6 and networks 7, 8 & 10 identified by the IPA tool (version 4.0) from up- and down-regulated gene analysis using overlapping genes (cf. Table 7). The network is displayed graphically as nodes (genes/gene products) and edges (the biological relationship between the nodes). The [PIP+] relative to[PIP-] over-expressed genes are shaded in light red and down-regulated genes in green. The genes connected with PIP (EGR2 and CD4) and STAT5B, which was identified by a promoter analysis as a potential key regulator of the master network, are shaded in yellow. The nodes are represented using various shapes that represent the functional class of the gene products. Highly interconnected nodes ('hub genes') are moved to the network periphery together with the PIP gene. The hub genes belonging to L235 are shaded in gray and those, which were detected by quantitative PCR, are underlined. The gene names are written in green (down-regulated) or in red (up-regulated) relative to a [PIP+] versus [PIP-] modulation. An asterisk refers to a gene that was not selected in L235, but was identified at another level of the statistical analysis (* for L578&L2231 and ** for L1114 & L2231, Table S1).
###end p 70
###begin p 71
###xml 160 163 160 163 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PIP</italic>
###xml 718 721 718 721 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PIP</italic>
###xml 755 759 755 759 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004696-Barabasi1">[72]</xref>
###xml 986 989 986 989 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PIP</italic>
###xml 998 1006 998 1006 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0004696-g004">Figure 4</xref>
###xml 1007 1011 1007 1011 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004696-Benson1">[73]</xref>
###xml 1440 1444 1440 1444 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004696-Chuang1">[74]</xref>
###xml 1679 1681 1679 1681 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">AR</italic>
###xml 1683 1687 1683 1687 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">IFNG</italic>
###xml 1689 1693 1689 1693 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">SPL1</italic>
###xml 1698 1701 1698 1701 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TNF</italic>
###xml 1741 1747 1741 1747 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CDKN2A</italic>
###xml 1752 1757 1752 1757 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">HDAC3</italic>
###xml 1811 1815 1811 1815 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">NRAS</italic>
###xml 1820 1824 1820 1824 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CD44</italic>
###xml 1948 1956 1948 1956 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0004696-g004">Figure 4</xref>
###xml 2017 2021 2017 2021 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">EGFR</italic>
###xml 2023 2028 2023 2028 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CCNA2</italic>
###xml 2034 2039 2034 2039 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TGFB1</italic>
###xml 2041 2045 2041 2045 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TP53</italic>
###xml 2094 2102 2094 2102 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0004696-g004">Figure 4</xref>
###xml 2259 2262 2259 2262 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MYC</italic>
###xml 2264 2268 2264 2268 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">BCL2</italic>
###xml 2270 2276 2270 2276 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CDKN1A</italic>
###xml 2278 2286 2278 2286 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0004696-g004">Figure 4</xref>
###xml 2464 2467 2464 2467 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">FN1</italic>
###xml 2469 2474 2469 2474 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CCNE1</italic>
###xml 2476 2481 2476 2481 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ERBB2</italic>
###xml 2483 2486 2483 2486 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">SP1</italic>
###xml 2579 2584 2579 2584 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ERBB2</italic>
###xml 2589 2592 2589 2592 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">SP1</italic>
###xml 2642 2650 2642 2650 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pone.0004696.s001">Table S1</xref>
A 231-member master molecular network has been assembled with 1,262 edges corresponding to a global view of gene expression modulations occurring together with PIP gene expression. This master network was constructed by merging the selected up- and down-regulated networks. The nodes and edges for each individual network were added to the merged network together with any new edges that connect these networks, resulting in incorporation of 29 additional genes. Nineteen nodes appeared to be highly connected in the network as demonstrated by the important number of edges emerging from or pointing to them. These nodes were considered as 'hub genes' and were moved to the periphery of the network, together with the PIP gene, in order to highlight them [72]. Their high connectivity is likely to reflect their ability to regulate an important number of genes within the master network and potentially to control the gene expression modulations identified between cells overexpressing PIP or not (Figure 4)[73]. Unexpectedly, of the 15 oncogenes and tumor suppressor genes included in the master network, 10 end up among the 19 hub genes, and 8 of them have been detected as differentially expressed through microarray and/or Q-PCR analyses. Such genes are usually not detected through analysis of differential expression, and are incorporated in predictive network modules only through integration of curated protein-protein interactions [74]. This highlights their central interconnecting role in the master network, and the value of using high-precision expression measurements with careful assessment of statistical power as performed in this study. All 19 hub genes except AR, IFNG, SPL1 and TNF were present on the array. Among them, CDKN2A and HDAC3 were identified as significantly over-expressed, and NRAS and CD44 as significantly decreased in [PIP+] versus [PIP-] samples, as detected by both microarray analysis (list L235) and Q-PCR (Figure 4, grey shaded symbols and underlined names). Four hub-genes (EGFR, CCNA2, and TGFB1, TP53 for up- and down-regulated genes, respectively; Figure 4, open symbols and underlined names) were not present in L235 but were found significantly differentially expressed by Q-PCR analysis only; three hub genes (MYC, BCL2, CDKN1A; Figure 4, asterisks) were found significantly differentially expressed by both Q-PCR and microarray analysis, belonging to other relevant computed gene lists. The remaining 4 hub genes (FN1, CCNE1, ERBB2, SP1) were not assayed by Q-PCR nor identified as differentially expressed by microarrays except ERBB2 and SP1 which were selected in lists L578 and L1114 (See Table S1). As molecular relationships represented on the network include not only induction or inhibition of expression, but also protein-protein interactions, DNA-protein interactions and activation, localization, inhibition of the corresponding proteins, it is not surprising that microarrays and Q-PCR may fail to identify some of the hub genes as being significantly modulated among the [PIP+] and [PIP-] subgroups of samples. These genes might play a major role through protein activation for instance. Alternatively, their modulations may be very subtle and below the threshold for reliable detection of differences of our microarray platform despite its high sensitivity. Distinguishing between these different possibilities will require targeted validation experiments.
###end p 71
###begin p 72
###xml 4 7 4 7 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PIP</italic>
###xml 114 117 114 117 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CD4</italic>
###xml 122 126 122 126 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">EGR2</italic>
###xml 128 136 128 136 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0004696-g004">Figure 4</xref>
###xml 159 162 159 162 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PIP</italic>
###xml 166 170 166 170 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">EGR2</italic>
###xml 278 281 278 281 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PIP</italic>
###xml 306 310 306 310 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">EGR2</italic>
###xml 310 314 310 314 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004696-Nagarajan1">[75]</xref>
###xml 316 320 316 320 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">EGR2</italic>
###xml 444 447 444 447 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PIP</italic>
###xml 474 477 474 477 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PIP</italic>
###xml 481 484 481 484 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CD4</italic>
###xml 661 665 661 665 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004696-Gaubin1">[19]</xref>
###xml 674 682 674 682 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vitro</italic>
###xml 220 223 <span type="species:ncbi:10116">rat</span>
The PIP gene was also moved to the periphery of the network, even though it is connected to only two other genes, CD4 and EGR2 (Figure 4). The edge connecting PIP to EGR2 was previously reported by a microarray study in rat Schwann cells, which demonstrated an up-regulation of PIP in cells overexpressing EGR2[75]. EGR2 cDNA clones are represented on the array but no significant modulation of its expression was observed in parallel with the PIP gene. The edge connecting PIP to CD4 is based on the reported interaction between these proteins leading to T lymphocyte programmed cell death inhibition induced by CD4 cross-linking and subsequent TCR activation [19]. In our in vitro models of breast cancer cell lines, the interaction between the secreted glycoprotein PIP and CD4 cannot take place since CD4 is not expressed in these cells.
###end p 72
###begin p 73
###xml 154 157 154 157 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">FN1</italic>
###xml 158 162 158 162 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004696-Caputo1">[20]</xref>
###xml 249 252 249 252 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PIP</italic>
###xml 257 260 257 260 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">FN1</italic>
###xml 325 328 325 328 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">FN1</italic>
###xml 365 373 365 373 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0004696-g004">Figure 4</xref>
###xml 479 482 479 482 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PIP</italic>
###xml 756 759 756 759 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PIP</italic>
###xml 794 802 794 802 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0004696-g004">Figure 4</xref>
In addition, previous studies reported that the PIP protein may exert an aspartyl proteinase activity able to specifically cleave fibronectin (encoded by FN1)[20], supporting a link between PIP and FN1 at the protein level. This interaction between PIP and FN1 is actually missing in the IPA database. In spite of this lack, FN1 appears as a hub gene in our study (Figure 4), thus supporting the strength of the genes identified as involved in the master network associated with PIP expression. This indicates that even though more than one million of functional, regulatory and physical interactions are included in the IPA knowledge database, its content is far from being exhaustive. Consequently, other interactions can be missed in the network of the PIP co-modulated genes represented in Figure 4.
###end p 73
###begin title 74
Promoter analysis of differentially expressed genes
###end title 74
###begin p 75
Co-regulation of mammalian genes usually depends on sets of transcription factors rather than on one individual factor. Therefore an analysis of the promoter regions of the genes from list L235 was conducted in order to identify potential common transcriptional regulators.
###end p 75
###begin p 76
###xml 78 82 78 82 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004696-httpwww.genomatix.deproductsElDoradoindex.html1">[76]</xref>
###xml 514 519 514 519 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ACOT2</italic>
###xml 521 527 521 527 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CEP250</italic>
###xml 529 538 529 538 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">GABARAPL1</italic>
###xml 540 545 540 545 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">NFRKB</italic>
###xml 547 551 547 551 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">NNMT</italic>
###xml 553 560 553 560 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PHACTR1</italic>
###xml 562 565 562 565 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PIP</italic>
###xml 567 572 567 572 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PLCB4</italic>
###xml 574 579 574 579 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PRAME</italic>
###xml 581 586 581 586 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PSEN2</italic>
###xml 588 592 588 592 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PSPH</italic>
###xml 594 598 594 598 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">RPN2</italic>
###xml 600 603 600 603 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">SAT</italic>
###xml 605 610 605 610 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">SC5DL</italic>
###xml 612 617 612 617 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">SEPT2</italic>
###xml 619 625 619 625 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">SLC1A4</italic>
###xml 627 633 627 633 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">SNRPA1</italic>
###xml 635 640 635 640 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">SNRPN</italic>
###xml 642 647 642 647 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">SNURF</italic>
###xml 649 654 649 654 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">SPARC</italic>
###xml 656 660 656 660 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">SRPR</italic>
###xml 662 667 662 667 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TCF25</italic>
###xml 669 674 669 674 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TEAD4</italic>
###xml 676 681 676 681 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TGFBI</italic>
###xml 683 688 683 688 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TMED2</italic>
###xml 788 792 788 792 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ALG3</italic>
###xml 794 799 794 799 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ANXA9</italic>
###xml 801 808 801 808 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ATP6AP2</italic>
###xml 810 817 810 817 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">B4GALT4</italic>
###xml 819 824 819 824 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">DHRS3</italic>
###xml 826 830 826 830 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">GDF5</italic>
###xml 832 836 832 836 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">HAX1</italic>
###xml 838 843 838 843 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">HDAC3</italic>
###xml 845 851 845 851 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">IQGAP1</italic>
###xml 853 861 853 861 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MPHOSPH6</italic>
###xml 863 868 863 868 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">NR1H3</italic>
###xml 870 876 870 876 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PEA-15</italic>
###xml 878 882 878 882 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PFN2</italic>
###xml 884 889 884 889 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">RAB13</italic>
###xml 891 896 891 896 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">REEP5</italic>
###xml 898 902 898 902 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">RFC4</italic>
###xml 904 910 904 910 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">SCAMP2</italic>
###xml 912 918 912 918 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">SEC22B</italic>
###xml 920 926 920 926 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">SLC2A1</italic>
###xml 928 934 928 934 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">SUCLA2</italic>
###xml 936 941 936 941 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TFPI2</italic>
###xml 943 947 943 947 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">THBD</italic>
###xml 949 954 949 954 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TNNT1</italic>
###xml 956 962 956 962 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TSPAN1</italic>
###xml 964 969 964 969 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TSTA3</italic>
###xml 971 976 971 976 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TULP1</italic>
Using the cluster ElDoradoe/Gene2promotor/GEMS Launcher for promoter analysis [76], three families of transcription factor binding sites (TFBS) were identified to be common to at least 40% of the genes from L235. They correspond to the glucocorticoid responsive and related elements (GREF), LEF1/TCF (LEFF) and the signal transducer and activator of transcription (STAT). The FrameWorker allowed the identification of a specific promoter framework constituted by all 3 TFBS and shared by 24 gene promoter regions (ACOT2, CEP250, GABARAPL1, NFRKB, NNMT, PHACTR1, PIP, PLCB4, PRAME, PSEN2, PSPH, RPN2, SAT, SC5DL, SEPT2, SLC1A4, SNRPA1, SNRPN, SNURF, SPARC, SRPR, TCF25, TEAD4, TGFBI, TMED2). Another set of 26 genes containing only a framework of 2 of the TFBS (GREF-STAT) was identified (ALG3, ANXA9, ATP6AP2, B4GALT4, DHRS3, GDF5, HAX1, HDAC3, IQGAP1, MPHOSPH6, NR1H3, PEA-15, PFN2, RAB13, REEP5, RFC4, SCAMP2, SEC22B, SLC2A1, SUCLA2, TFPI2, THBD, TNNT1, TSPAN1, TSTA3, TULP1). Specifically, STAT5 transcription factor binding sites were implicated in this GREF-STAT motif. Additionally, a TFBS from the STAT motif family only was identified in the promoter region of several other genes from L235 (data not shown).
###end p 76
###begin p 77
###xml 61 69 61 69 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0004696-g004">Figure 4</xref>
###xml 106 112 106 112 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">STAT5B</italic>
###xml 126 130 126 130 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">BCL2</italic>
###xml 132 137 132 137 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CCND1</italic>
###xml 139 143 139 143 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CCR5</italic>
###xml 145 151 145 151 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CDKN1A</italic>
###xml 153 156 153 156 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">EGF</italic>
###xml 158 161 158 161 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">EPO</italic>
###xml 163 168 163 168 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ERBB2</italic>
###xml 170 173 170 173 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">GH1</italic>
###xml 175 179 175 179 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">HEXA</italic>
###xml 181 186 181 186 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">IFNA1</italic>
###xml 188 192 188 192 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">IFNG</italic>
###xml 194 198 194 198 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">INS1</italic>
###xml 200 205 200 205 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">KITLG</italic>
###xml 207 213 207 213 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">NOTCH4</italic>
###xml 215 220 215 220 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PPARA</italic>
###xml 222 227 222 227 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PTK2B</italic>
###xml 229 234 229 234 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TGFB1</italic>
###xml 239 243 239 243 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">THRB</italic>
###xml 305 311 305 311 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">STAT5B</italic>
###xml 313 316 313 316 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">EGF</italic>
###xml 318 321 318 321 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">EPO</italic>
###xml 323 328 323 328 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">IFNA1</italic>
###xml 330 334 330 334 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">IFNG</italic>
###xml 339 343 339 343 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PYK2</italic>
###xml 397 401 397 401 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004696-Kloth1">[77]</xref>
###xml 402 406 402 406 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004696-Hwa1">[81]</xref>
###xml 415 420 415 420 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TGFB1</italic>
###xml 458 462 458 462 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004696-Brizzi1">[82]</xref>
###xml 546 554 546 554 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0004696-g004">Figure 4</xref>
###xml 596 602 596 602 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">STAT5A</italic>
###xml 653 659 653 659 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">STAT5A</italic>
###xml 698 704 698 704 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">STAT5B</italic>
###xml 716 721 716 721 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CCND1</italic>
###xml 723 727 723 727 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CCR5</italic>
###xml 729 734 729 734 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ERBB2</italic>
###xml 736 740 736 740 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">HEXA</italic>
###xml 742 747 742 747 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PPARA</italic>
###xml 749 754 749 754 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PTK2B</italic>
###xml 756 761 756 761 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TGFB1</italic>
###xml 766 770 766 770 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">THRB</italic>
###xml 846 852 846 852 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">BCL2L1</italic>
###xml 854 858 854 858 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">EGFR</italic>
###xml 860 863 860 863 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MYC</italic>
###xml 865 870 865 870 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">NFKB1</italic>
###xml 872 877 872 877 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">NR3C1</italic>
###xml 882 885 882 885 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TNF</italic>
###xml 902 905 902 905 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TNF</italic>
###xml 910 915 910 915 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">NFKB1</italic>
###xml 958 964 958 964 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">STAT5A</italic>
###xml 964 968 964 968 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004696-Banno1">[83]</xref>
###xml 970 974 970 974 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004696-Hinata1">[84]</xref>
In the master network of the differentially expressed genes (Figure 4),a high number of interactions with STAT5B is observed (BCL2, CCND1, CCR5, CDKN1A, EGF, EPO, ERBB2, GH1, HEXA, IFNA1, IFNG, INS1, KITLG, NOTCH4, PPARA, PTK2B, TGFB1 and THRB). Several of these genes appear to be upstream regulators of STAT5B: EGF, EPO, IFNA1, IFNG and PYK2 have been shown to increase the activation of STAT5B [77]-[81] whereas TGFB1 was shown to increase its expression [82]. In contrast to STAT5B, STAT5A is not represented in the assembled master network (Figure 4). Analysis of known interactions between STAT5A and the genes from the master network showed that STAT5A share almost the same interactions as STAT5B except for CCND1, CCR5, ERBB2, HEXA, PPARA, PTK2B, TGFB1 and THRB (data not shown). Moreover additional interactions have been reported with BCL2L1, EGFR, MYC, NFKB1, NR3C1 and TNF. In particular, TNF and NFKB1 have been shown to increase expression of STAT5A[83], [84].
###end p 77
###begin p 78
###xml 154 158 154 158 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004696-Humphreys1">[85]</xref>
###xml 159 163 159 163 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004696-Bertucci1">[87]</xref>
###xml 225 229 225 229 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004696-Nevalainen1">[88]</xref>
###xml 231 235 231 235 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004696-Sultan1">[89]</xref>
###xml 415 419 415 419 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004696-Sultan1">[89]</xref>
###xml 420 424 420 424 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004696-Barash1">[91]</xref>
###xml 507 511 507 511 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004696-Sultan1">[89]</xref>
###xml 574 582 574 582 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vitro</italic>
###xml 647 651 647 651 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004696-Nevalainen1">[88]</xref>
###xml 784 788 784 788 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004696-Nouhi1">[90]</xref>
###xml 858 862 858 862 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004696-Nouhi1">[90]</xref>
###xml 990 994 990 994 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004696-Gutzman1">[92]</xref>
###xml 1154 1158 1154 1158 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004696-Nevalainen1">[88]</xref>
###xml 1160 1164 1160 1164 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004696-Cotarla1">[93]</xref>
###xml 140 146 <span type="species:ncbi:10090">murine</span>
###xml 199 204 <span type="species:ncbi:9606">human</span>
###xml 693 698 <span type="species:ncbi:9606">human</span>
###xml 1084 1089 <span type="species:ncbi:9606">human</span>
Previous studies described that STAT5 may exhibit opposite functions in mammary oncogenesis, either increasing tumor development in several murine models [85]-[87] or inhibiting tumor progression in human breast cancer cells [88], [89]. More recently, it has been proposed that STAT5 may act as a suppressor of invasion, epithelial mesenchymal transition and dispersal of breast cancer cells from the primary tumor [89]-[91]. This was novel in light of the previous tumor-promoting role attributed to STAT5 [89]. The suppressive role of STAT5 on cell invasion was confirmed in vitro in the well-differentiated ER-positive breast cancer cells T47D [88]. It was also shown that PRL may suppress human breast cancer cell invasion through multiple mechanisms, such as activation of STAT5 [90]. Indeed, STAT5, one of the main downstream effector molecules of PRL [90], has been shown to directly modulate transcriptional activity through interaction with the promoter region of the target genes [92]. Moreover, high levels of activated STAT5 have been found in a substantial proportion of human breast tumors, which interestingly exhibited a better prognosis [88], [93].
###end p 78
###begin p 79
###xml 15 18 15 18 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PIP</italic>
###xml 341 353 341 353 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PIP/GCDFP-15</italic>
###xml 359 363 359 363 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004696-Carsol1">[94]</xref>
Interestingly, PIP gene expression was previously reported to be synergistically induced by prolactin (PRL)-activated STAT5 and DHT-activated AR. More precisely PRL-induced phosphorylation on Tyr694 of STAT5A and Tyr699 of STAT5B was demonstrated to be required for the synergistic effect of DHT and PRL on transcriptional activation of the PIP/GCDFP-15 gene [94].
###end p 79
###begin p 80
###xml 61 66 61 66 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">STAT5</italic>
###xml 154 162 154 162 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0004696-g004">Figure 4</xref>
###xml 180 183 180 183 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PIP</italic>
###xml 241 247 241 247 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">STAT5A</italic>
###xml 252 258 252 258 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">STAT5B</italic>
###xml 268 271 268 271 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PIP</italic>
###xml 644 648 644 648 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004696-Nouhi1">[90]</xref>
Altogether, our results suggest the potential involvement of STAT5 in the transcriptional regulation of several genes from the master network identified (Figure 4) associated with PIP. The failure to detect significant expression changes of STAT5A and STAT5B genes in PIP expressing versus non expressing breast carcinoma cells using microarray analysis suggests that the protective effects of these transcription factors on breast carcinoma development could be mainly due to their activation rather than to modifications of their gene expression levels. This hypothesis, supported by the suppression of cell invasion through STAT5 activation [90], will have to be further investigated in future studies.
###end p 80
###begin p 81
###xml 108 111 108 111 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PIP</italic>
###xml 328 331 328 331 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PIP</italic>
###xml 540 543 540 543 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PIP</italic>
###xml 792 795 792 795 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PIP</italic>
###xml 934 939 934 939 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ERBB2</italic>
###xml 944 948 944 948 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TP53</italic>
###xml 1124 1128 1124 1128 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004696-Chuang1">[74]</xref>
###xml 1353 1356 1353 1356 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PIP</italic>
In summary, we report here a comprehensive characterization of the gene expression modulations occurring in PIP-expressing versus non-expressing breast cancer cell lines. Using rigorous unsupervised and supervised analyses, we identified differentially expressed genes, which were found strictly co-modulated in relation to the PIP expression level changes and allowed us to discriminate [PIP+] and [PIP-] subgroups of samples. This study provides useful information in term of pathway modulations that occur within breast cells expressing PIP. The combination of a high-precision expression profiling with an extensive functional and regulatory network analysis has emphasized a central interconnecting role of a number of oncogenes and tumor suppressor genes in the network associated with PIP expression modulation. Many oncogenes and tumor suppressor genes, previously reported to exhibit particular breast cancer mutations, e.g. ERBB2 and TP53, are typically not detected through analysis of differential expression but can play a central role in signalling networks by interconnecting many expression-responsive genes [74]. Interestingly, half of them were found significantly differentially expressed with an increase level of PIP transcript. Consequently, our data allowed determination of a global view of the regulatory network resulting from PIP overexpression based on the aggregate behaviour of genes connected in a functional network rather than on unique genes found differentially expressed.
###end p 81
###begin p 82
###xml 87 90 87 90 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PIP</italic>
###xml 341 344 341 344 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PIP</italic>
###xml 562 566 562 566 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004696-Fritzsche1">[95]</xref>
###xml 610 619 610 619 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in silico</italic>
###xml 669 672 669 672 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PIP</italic>
###xml 1174 1178 1174 1178 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004696-Nevalainen1">[88]</xref>
###xml 1180 1184 1180 1184 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004696-Sultan1">[89]</xref>
Functionally, the gene expression modulations associated with an increase of levels of PIP transcript appear associated with an inhibition of proliferation coupled with an enhancement of the apoptosis and the cell adhesion in breast cancer cell lines. These results provide additional and contextual support for the good prognostic value of PIP gene expression in breast cancer, as recently demonstrated by immunohistochemistry on a large cohort of tumor samples in which significantly longer disease-free survival times were associated with PIP positive tumors [95]. In addition, STAT5 was identified through in silico promoter analyses of the genes co-modulated with PIP suggesting that it might be a transcriptional regulator accounting for the observed altered functions. This unexpected result supports the view that an important part of the modulated genes act as upstream or downstream effectors of STAT5. For some of them, there is no experimental evidence of a relationship with STAT5 and additional experiments would be required to confirm this point. Finally, STAT5 is known to inhibit cell invasion and is considered as a good prognostic factor in breast cancer [88], [89].
###end p 82
###begin p 83
###xml 29 36 29 36 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="pone-0004696-t007">Table 7</xref>
###xml 95 103 95 103 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0004696-g004">Figure 4</xref>
###xml 360 368 <span type="species:ncbi:9606">patients</span>
Many of the groups of genes (Table 7) that form the basis of the master network reported here (Figure 4), including those discussed above, represent novel combinations of factors that may impact on important cancer-initiating biological processes or that may be modulated consequentially. Further biological and clinical investigations using a large cohort of patients will be necessary to identify those which contribute directly to breast cancer development and progression, have prognostic value and are possible targets for therapeutic intervention.
###end p 83
###begin title 84
Materials and Methods
###end title 84
###begin title 85
Cell lines and culture conditions
###end title 85
###begin p 86
###xml 118 122 118 122 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004696-Vandewalle1">[96]</xref>
###xml 439 440 435 436 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 330 334 <span type="species:ncbi:9913">calf</span>
T47D, MCF7, MDA-MB231 breast carcinoma cell lines were obtained from the American Type Culture Collection. VHB1 cells [96] were a gift from J. Soudon (Hopital Saint-Louis, Paris, France). Cells were maintained in Dulbecco's modified Eagle's medium (DMEM) with GlutaMAX (Invitrogen Ltd., Paisley, UK), supplemented with 10% foetal calf serum (Perbio Sciences, Helsingborg, Sweden), 100 U/ml penicillin, 100 microg/ml streptomycin in a 5% CO2 incubator. Cells were treated with 10 nM Dihydrotestosterone (DHT; Sigma #A8380, St Louis, MO) for 6, 7, 8 or 10 days before RNA extraction.
###end p 86
###begin title 87
RNA extraction
###end title 87
###begin p 88
###xml 613 617 613 617 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004696-Imbeaud1">[97]</xref>
###xml 619 623 619 623 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004696-Schroeder1">[98]</xref>
###xml 260 265 <span type="species:ncbi:9606">human</span>
Total RNA was extracted from monolayer cells in culture at 2/3 confluency using the RNeasy Mini Kit (Qiagen, Hilden, Germany). RNA purity and quantity was assessed by UV measurement. Healthy mammary gland RNA from three distinct healthy donors and a universal human reference RNA were obtained from commercial sources (Stratagene Europe, Amsterdam, Netherlands). RNA integrity was judged using RNA 6000 nano chips and the Agilent 2100 Bioanalyzer (Agilent Technologies, Palo Alto, CA) according to the manufacturer's instructions. RNA quality-control was performed using user-independent classifiers as described [97], [98].
###end p 88
###begin title 89
Northern blot analysis
###end title 89
###begin p 90
###xml 238 242 234 238 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004696-Maniatis1">[99]</xref>
###xml 271 273 263 265 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">32</sup>
###xml 358 363 349 354 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004696-Autiero5">[100]</xref>
###xml 365 370 356 361 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004696-Alonso1">[101]</xref>
###xml 431 433 416 418 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">32</sup>
###xml 457 458 442 443 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">6</sup>
Total RNAs (15-50 microg) from breast carcinoma cell lines were electrophoresed in a 1.6% formaldehyde agarose gel and transferred onto Hybond-N nylon membranes (Amersham Biosciences, Buckinghamshire, UK) according to standard techniques [99]. Probes labeled with [alpha-32P] dCTP (3000 Ci/mmol; Amersham Biosciences) were full-length PIP and ss-actin cDNAs [100], [101]. Northern blots were hybridized at 68degreesC for 16 h with 32P-labeled probes (1.5x106 cpm/ml) in ExpressHyb Hybridization solution (BD Biosciences Clontech), washed twice in 2x SSC/0.05% SDS at room temperature for 30 min and twice in 0.1x SSC/0.1% SDS at 50degreesC for 45 min. Membranes were then autoradiographed at -80degreesC on Kodak X-Omat AR X-ray films (Kodak, Rochester, NY).
###end p 90
###begin title 91
Microarray design and manufacture
###end title 91
###begin p 92
###xml 140 145 140 145 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004696-Graudens1">[102]</xref>
###xml 557 562 557 562 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004696-Graudens1">[102]</xref>
###xml 643 648 643 648 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004696-httpfre2571.vjf.cnrs.fr1">[103]</xref>
###xml 801 806 801 806 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004696-Graudens1">[102]</xref>
###xml 4 9 <span type="species:ncbi:9606">human</span>
The human cDNA microarrays used contained 11,520 sequences derived from various sequence-verified clone collections as previously described [102]. The array set provides a genome-wide coverage of functional pathways, such as cell cycle and checkpoints, cell growth and/or maintenance, cell adhesion and proliferation, development, extracellular matrix, apoptosis, response to DNA damage and DNA repair, DNA replication, transcription and RNA processing. High confidence qualifications and annotations of the clone collections have been previously described [102] and are available through our web site (The Genexpress - Array s/IMAGE web site,[103]). All arrays were printed in the laboratory on amino-modified mirrored glass slides using the Lucidea array spotter (Amersham Biosciences) as described [102]. The suite of amplified cDNAs was printed as a group in two spatially separated replicates.
###end p 92
###begin title 93
Hybridization experimental design and analysis
###end title 93
###begin p 94
###xml 669 674 669 674 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004696-Graudens1">[102]</xref>
To reduce potential experimental biases, four independent RNA preparations were collected for each DHT-treated and -untreated cell lines. To assess data reproducibility and minimize dye bias effects, each of the samples was measured twice, once with Cy3 and once with Cy5. To ensure robustness and flexibility in data analysis, a reference design was used with a universal reference sample (Stratagene) serving as a baseline for the comparisons of cell line samples. Such a design does not require pre-definition of the subgroups for comparison, allows robust discovery of non-anticipated classes among the samples and is compatible with subsequent additional sampling [102].
###end p 94
###begin p 95
###xml 447 452 443 448 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004696-Graudens1">[102]</xref>
###xml 511 516 507 512 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004696-Graudens1">[102]</xref>
###xml 1762 1767 1758 1763 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004696-httpimage.llnl.gov1">[104]</xref>
###xml 1990 1995 1986 1991 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004696-Brazma1">[105]</xref>
###xml 2061 2066 2057 2062 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004696-httpwww.ncbi.nlm.nih.govgeo1">[106]</xref>
###xml 51 56 <span type="species:ncbi:9606">human</span>
###xml 1736 1748 <span type="species:ncbi:9606">Homo sapiens</span>
Thirty microg of total RNA from each cell line and human universal reference RNA (Stratagene) were supplemented with known sequences (spikes, Universal ScoreCard), reverse transcribed using an oligo-dT primer and labeled alternatively with Cy-5-dCTP and Cy-3-dCTP (Amersham Biosciences). Samples were purified using the Qiagen's QIAquick PCR Purification kit procedure and submitted to a vigilant quality control procedure as previously described [102]. Hybridizations to the arrays were performed as described [102]. Array images and raw data were obtained using the GenIII array scanner (Amersham Biosciences) and ArrayVision 7.0 software (Imaging Research Inc., Amersham Biosciences, Palo Alto, CA, USA). Raw data were first imported into a Genetraffic duo database (Iobion Informatics, Toronto, Canada), local background-subtracted and normalized using a Lowess (locally weighted linear regression) transformation. The following selection criteria were applied: all spots having a mean signal (after background subtraction) less than that of the background and below that of the negative controls in both Cy3 and Cy5 channels were systematically excluded; the data were also filtered to exclude spots flagged as missing or corrupted in one array. For arrays considered as partially exploitable based on several quality criteria additional hybridizations were done and considered as technical replicates. We next calculated the average expression ratios (test/reference) in all analyses. Log2 values of lowess-transformed data were used for all subsequent statistical analyses. For reporting genes by name, IMAGE Clone IDs corresponding to the microarray probe sequences were used to extract UniGene Cluster IDs and names (Build 199 Homo sapiens; Jan 16 2007)[104]. For genes represented by multiple probes (that is, different clones corresponding to the same gene) on the array, each probe and the related expression ratios were considered and reported separately. MIAME-compliant data [105] have been deposited in the Gene Expression Omnibus (GEO) at NCBI [106] and are accessible through GEO Series accession number GSE11627.
###end p 95
###begin title 96
Modeling of experimental power
###end title 96
###begin p 97
###xml 178 183 178 183 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004696-Graudens1">[102]</xref>
###xml 226 231 226 231 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004696-Hwang1">[107]</xref>
###xml 266 271 266 271 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004696-httpwww.psycho.uniduesseldorf.deabteilungenaapgpower31">[108]</xref>
###xml 273 278 273 278 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004696-Faul1">[109]</xref>
For statistical confidence and power analyses related to this specific program, power (z-score) for an unpaired t-test (two-sample analyses) was computed as previously described [102] for estimation of false discoveries (FDR) [107] and using the GPower3.0.3 program [108], [109] for estimation of false negatives (FNR), taking into account the standard deviation of expression measurements, the size of the distinct sample groups, a significance threshold and the fold ratio to be detected.
###end p 97
###begin p 98
###xml 0 8 0 8 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A priori</italic>
###xml 125 133 125 133 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">post hoc</italic>
A priori power analyses were used to choose the appropriate number of replicates before the study was conducted. Conversely, post hoc power calculations were done to evaluate the actual power reached in our study.
###end p 98
###begin title 99
Hierarchical clustering
###end title 99
###begin p 100
###xml 650 655 650 655 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004696-Eisen1">[110]</xref>
###xml 718 723 718 723 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004696-Eisen1">[110]</xref>
For discriminant analysis of overall variation in samples/genes, median centering and normalization of the genes and samples were applied to the entire dataset. Genes which had missing values in more than 20% of the samples were removed from subsequent analysis. An unsupervised average-linkage hierarchical clustering algorithm using a centered Pearson correlation as similarity metric was applied to investigate relationships between samples and relationships between genes. This method leads to an expression matrix such that genes and samples with similar expression patterns are adjacent to each other. This analysis was performed using Cluster [110] and the resulting expression map was visualized with TreeView [110].
###end p 100
###begin p 101
###xml 356 357 356 357 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">t</italic>
###xml 443 444 443 444 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">t</italic>
###xml 473 478 473 478 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004696-Rhodes1">[111]</xref>
For discriminant analysis of differentially expressed genes, an average-linkage hierarchical clustering with uncentered Pearson correlation was applied to the dataset extracted from the list of the genes selected to be differentially expressed. Mean sample profiles and gene profiles were ranked based on a discrimination score, which is equivalent to the t-statistics z-score, using the Cluster Identification Tool (CIT), based on supervised t-statistics with permutation [111]. Discriminant analysis of the [PIP+] and [PIP-] samples was performed, providing a list of gene nodes that exhibit statistically significant differential expression between the two groups (alpha</=0.05).
###end p 101
###begin title 102
Statistical analysis
###end title 102
###begin p 103
###xml 928 929 928 929 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">t</italic>
###xml 949 950 949 950 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">F</italic>
###xml 1062 1067 1062 1067 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004696-Benjamini1">[112]</xref>
###xml 1211 1212 1211 1212 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
The statistical significance of measured intensity differences was tested using ArrayStat 1.0 software (Imaging Research Inc.). The whole data sets were adjusted using additive statistical models considering samples with homogeneous phenotypes ([PIP++], [PIP+] or [PIP-]) as replicates measures from one condition, with a minimum of 67-75% registered measures per gene. Offset corrections were applied to compensate any potential systematic errors that may exist within data for each condition across arrays. Random error was estimated using a curve-fit method; outliers were automatically detected and then excluded from subsequent analysis, based on thresholds computed over the entire dataset (in median absolute deviation (MAD) and standard deviation (sd) units). For [PIP+] vs [PIP-], [PIP+] J = 0 vs [PIP-] J = 0, [PIP+] J = 7 vs [PIP-] J = 7 and J = 0 vs J = 7 comparisons, data sets were centered for each condition and t-, Z-statistics and F-statistics were applied with false discovery rate (FDR) corrections to compensate for multiple testing effects [112]. Data from genes with significant differential expression levels between the two compared subgroups were displayed, together with a two-tailed p-value adjusted with alpha = 0.01.
###end p 103
###begin p 104
###xml 115 120 115 120 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004696-Tusher1">[113]</xref>
###xml 273 274 273 274 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">t</italic>
###xml 310 311 310 311 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">t</italic>
###xml 558 561 558 561 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PIP</italic>
Independent statistical analysis was achieved using SAM (Significant Analysis of Microarrays, Standford University)[113]. This class comparison method uses a modified t-test to identify genes that discriminate, for example, [PIP+] samples from [PIP-] samples. The modified t-test involves carrying out typical t-tests for each gene using the original data and a user-specified number of permuted datasets generated by randomly shuffling of the class labels. We conducted SAM analysis based on the microarray intensity level (in arbitrary units, A.U.) of the PIP gene in samples (T47D J = 0:20 000 A.U.; T47D J = 7:30 000 A.U.; VHB1 J = 0:800 A.U.; VHB1 J = 7:7 000 A.U.; MCF7 J = 0 and J = 7:800 A.U.; MDA-MB231 J = 0:1 000 A.U.; MDA-MB231 J = 7:1 500 A.U.) using a false positive rate of 0.01 and a number of permutations of 2 000.
###end p 104
###begin title 105
Real-time Quantitative RT-PCR (Q-PCR) analysis using Taqman Low Density Arrays
###end title 105
###begin p 106
###xml 132 137 132 137 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004696-httpwww.appliedbiosystems.com1">[114]</xref>
Pre-defined TaqMan probe and primer sets for target genes were chosen from an on-line database (Applied Biosystems, Foster City, CA,[114]). The sets were factory-loaded into 384 well microfluidic cards (Applied Biosystems) as customized with two replicates per target gene. Single-stranded cDNA was prepared from 1 microg of total RNA from breast carcinoma cell lines using the high capacity cDNA archive kit (Applied Biosystems), according to the manufacturer's instructions. Breast carcinoma cell line RNA samples derived from identical preparations for both cDNA microarray and Q-PCR analysis.
###end p 106
###begin p 107
###xml 319 320 303 304 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">g</italic>
Two microl of single-stranded cDNA (equivalent to 100 ng of total RNA) were mixed with 48 microl of nuclease-free water and 50 microl of TaqMan Universal PCR Master Mix (Applied Biosystems). The sample-specific PCR mixture (100 microl) was loaded into one sample port, the cards were centrifuged twice for 1 min at 280 g and sealed to prevent well-to-well contamination. The cards were placed in the Micro Fluidic Card Sample Block of an ABI Prism 7900 HT Sequence Detection System (Applied Biosystems). The thermal cycling conditions were 2 min at 50 degreesC and 10 min at 95 degreesC, followed by 40 cycles of 30 s at 97 degreesC and 1 min at 59.7 degreesC. 96 genes were tested by quantitative PCR, using the TaqMan low density micro fluidic card (Applied Biosystems, USA). Raw data are available upon request.
###end p 107
###begin title 108
Network and Gene Ontology analysis
###end title 108
###begin p 109
###xml 341 346 341 346 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004696-httpswww.ingenuity.com1">[115]</xref>
###xml 589 590 589 590 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
The differentially expressed genes were used for pathway and Gene Ontology analyses. Locuslink ID gene accession numbers and their corresponding fold changes in our experiment were imported into the Ingenuity Pathway Analysis (IPA) tool and mapped to its corresponding gene object in the Ingenuity Pathways Knowledge Base (Ingenuity Systems,[115]). Genes were categorized based on their molecular functions using the software, mapped onto genetic networks in the IPA database and then ranked by score. The score associated with a particular network is the likehood (i.e. negative log of a p-value) of the genes identified as differentially expressed in a network being found together due to chance. The score is thus indicative of the proportion of genes identified as differentially expressed in our analysis among all the genes belonging to a particular network. A score of 3 reflects the likelihood that the presence of the focus genes in a network is solely due to chance is 1/1000. Therefore, scores of 3 or higher represent a >99.9% confidence level. Genes and gene products are represented as nodes and the biological relationship between two nodes is represented as an edge (line).
###end p 109
###begin p 110
###xml 376 377 372 373 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
In functional analyses, the biological functions that were most significant to the dataset were identified. The significance value assigned to the functions is calculated using the one-side right-tailed Fisher's Exact Test (alpha = 0.05) of the IPA tool. In this statistical test, the chances that the genes-of-interest participate in the biological functions are examined. A p-value is calculated by comparing the number of genes-of-interest in a particular function with their occurrences in all the functions in the IPA knowledge database.
###end p 110
###begin title 111
Promoter sequence analysis
###end title 111
###begin p 112
###xml 109 113 109 113 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004696-httpwww.genomatix.deproductsElDoradoindex.html1">[76]</xref>
###xml 4 9 <span type="species:ncbi:9606">human</span>
The human promoter sequences for all genes from L235 were extracted with the ElDoradoe/Gene2promotor system ([76]; default 500-bp upstream of the transcription start site and 100-bp downstream). The GEMS Launcher software was used to search for common transcription factor binding sites (TFBSs) in multiple sequences. The quorum constraint which determines the lower limit of loci within the input set that has to contain the common framework was set to 40% (core similarity 1). The selection of matrices associated with specific tissue was restricted to breast tissue.
###end p 112
###begin p 113
###xml 46 51 46 51 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004696-httpwww.genomatix.deproductsGEMSLauncherindex.html1">[116]</xref>
The FrameWorker task of GEMS Launcher package [116] was then used to retrieve common motifs (frameworks) of transcription factor binding sites in the promoter region of the input genes.
###end p 113
###begin title 114
Supporting Information
###end title 114
###begin p 115
Origins of gene lists derived from class comparison and class prediction of relative expression levels. Differential expression analyses were conducted to identify genes co-modulated with PIP using several statistical t-, z- and F-tests and an I+/- of 0.01. These analyses were conducted initially with a two-phenotype sample classification [PIP-] and [PIP+] and further partitioning the [PIP+] group in two subgroups, in order to anticipate potential genes co-regulation in relation with the PIP expression. The list L219 represents the intersection (intersection) of several gene lists (L606, L964, L1114 and L1184) whereas L2231 correspond to the union (union or logical sum) of these lists. * Quantitative analysis was based on the microarray intensity level (in arbitrary units, A.U.) of the PIP gene in samples: T47D J = 0:20 000 A.U.; T47D J = 7:30 000 A.U.; VHB1 J = 0:800 A.U.; VHB1 J = 7:7 000 A.U.; MCF7 J = 0 and J = 7:800 A.U.; MDA-MB231 J = 0:1 000 A.U.; MDA-MB231 J = 7:1 500 A.U.
###end p 115
###begin p 116
(0.02 MB XLS)
###end p 116
###begin p 117
Click here for additional data file.
###end p 117
###begin p 118
Descriptive statistics and annotation of differentially expressed genes from L235.
###end p 118
###begin p 119
(0.21 MB XLS)
###end p 119
###begin p 120
Click here for additional data file.
###end p 120
###begin p 121
We are grateful to Cindy Mollard and Corinne Leclerq for technical assistance. We thank Dr Jessica Zucman-Rossi for having given access to the Applied Biosystems 7900 HT Fast real-Time PCR system and for helpful advice concerning the implementation of the Q-PCR processes. The authors would also like to thank Dr J. Guardiola and Dr Esther Graudens for helpful discussions.
###end p 121
###begin title 122
References
###end title 122
###begin article-title 123
ABC of breast diseases. Breast cancer epidemiology, risk factors and genetics.
###end article-title 123
###begin article-title 124
Risk-group discrimination in node-negative breast cancer using invasion and proliferation markers: 6-year median follow-up.
###end article-title 124
###begin article-title 125
The genetics of sporadic breast cancer.
###end article-title 125
###begin article-title 126
Apocrine adenosis: a precursor of aggressive breast cancer?
###end article-title 126
###begin article-title 127
###xml 105 110 <span type="species:ncbi:9606">human</span>
Gross cystic disease fluid protein-15 as a marker for breast cancer: immunohistochemical analysis of 690 human neoplasms and comparison with alpha-lactalbumin.
###end article-title 127
###begin article-title 128
Serous papillary adenocarcinoma of the female genital organs and invasive micropapillary carcinoma of the breast. Are WT1, CA125, and GCDFP-15 useful in differential diagnosis?
###end article-title 128
###begin article-title 129
Value of GCDFP-15 (BRST-2) as a specific immunocytochemical marker for breast carcinoma in cytologic specimens.
###end article-title 129
###begin article-title 130
The enigmatic nature of apocrine breast lesions.
###end article-title 130
###begin article-title 131
Metastatic adenocarcinoma to the brain: an immunohistochemical approach.
###end article-title 131
###begin article-title 132
Immunohistochemical detection of breast specific antigens and cytokeratins in metastatic breast carcinoma in the liver.
###end article-title 132
###begin article-title 133
Value of gross cystic disease fluid protein-15 in distinguishing metastatic breast carcinomas among poorly differentiated neoplasms involving the ovary.
###end article-title 133
###begin article-title 134
Panels of immunohistochemical markers help determine primary sites of metastatic adenocarcinoma.
###end article-title 134
###begin article-title 135
###xml 65 70 <span type="species:ncbi:9606">human</span>
Expression of the gene encoding a prolactin-inducible protein in human breast cancers in vivo: a correlation with steroid receptor status.
###end article-title 135
###begin article-title 136
###xml 72 77 <span type="species:ncbi:9606">human</span>
The potential role for prolactin-inducible protein (PIP) as a marker of human breast cancer micrometastasis.
###end article-title 136
###begin article-title 137
Biochemistry and immunochemistry of gross cystic disease fluid proteins of the breast.
###end article-title 137
###begin article-title 138
###xml 109 114 <span type="species:ncbi:9606">human</span>
Interaction of seminal plasma proteins with cell surface antigens: presence of a CD4-binding glycoprotein in human seminal plasma.
###end article-title 138
###begin article-title 139
###xml 45 50 <span type="species:ncbi:9606">human</span>
A 17 kDa CD4-binding glycoprotein present in human seminal plasma and in breast tumor cells.
###end article-title 139
###begin article-title 140
Mapping the interaction site between CD4 and gp17, a glycoprotein secreted from seminal vesicles and breast carcinomas.
###end article-title 140
###begin article-title 141
Potent inhibition of CD4/TCR-mediated T cell apoptosis by a CD4-binding glycoprotein secreted from breast tumor and seminal vesicle cells.
###end article-title 141
###begin article-title 142
A novel aspartyl proteinase from apocrine epithelia and breast tumors.
###end article-title 142
###begin article-title 143
###xml 39 44 <span type="species:ncbi:9606">human</span>
Initial sequencing and analysis of the human genome.
###end article-title 143
###begin article-title 144
###xml 56 61 <span type="species:ncbi:9606">human</span>
Abnormal restriction pattern of PIPgene associated with human primary prostate cancers.
###end article-title 144
###begin article-title 145
Intragenic amplification and formation of extrachromosomal small circular DNA molecules from the PIP gene on chromosome 7 in primary breast carcinomas.
###end article-title 145
###begin article-title 146
###xml 133 136 133 136 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PIP</italic>
###xml 93 98 <span type="species:ncbi:9606">human</span>
Initiation of the breakage-fusion-bridge mechanism through common fragile site activation in human breast cancer cells: the model of PIP gene duplication from a break at FRA7I.
###end article-title 146
###begin article-title 147
###xml 120 125 <span type="species:ncbi:9606">human</span>
Association of increased basement membrane invasiveness with absence of estrogen receptor and expression of vimentin in human breast cancer cell lines.
###end article-title 147
###begin article-title 148
###xml 37 42 <span type="species:ncbi:9606">human</span>
Regulation of GCDFP-15 expression in human mammary cancer cells.
###end article-title 148
###begin article-title 149
Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implications.
###end article-title 149
###begin article-title 150
###xml 80 85 <span type="species:ncbi:9606">human</span>
Inhibitory effect of estrogens on GCDFP-15 mRNA levels and secretion in ZR-75-1 human breast cancer cells.
###end article-title 150
###begin article-title 151
Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method.
###end article-title 151
###begin article-title 152
BCL-2 family: regulators of cell death.
###end article-title 152
###begin article-title 153
Cell cycle arrest and inhibition of tumor cell proliferation by the p16INK4 gene mediated by an adenovirus vector.
###end article-title 153
###begin article-title 154
###xml 67 72 <span type="species:ncbi:9606">human</span>
Adenovirus-mediated p16INK4 gene transfer significantly suppresses human breast cancer growth.
###end article-title 154
###begin article-title 155
Growth-inhibitory activity and downregulation of the class II tumor-suppressor gene H-rev107 in tumor cell lines and experimental tumors.
###end article-title 155
###begin article-title 156
Tumor-associated antigen preferentially expressed antigen of melanoma (PRAME) induces caspase-independent cell death in vitro and reduces tumorigenicity in vivo.
###end article-title 156
###begin article-title 157
Invasiveness of breast carcinoma cells and transcript profile: Eph receptors and ephrin ligands as molecular markers of potential diagnostic and prognostic application.
###end article-title 157
###begin article-title 158
c-Myc and cyclin D3 (CcnD3) genes are independent targets for glucocorticoid inhibition of lymphoid cell proliferation.
###end article-title 158
###begin article-title 159
###xml 81 86 <span type="species:ncbi:9606">human</span>
Wild-type p16INK4a suppresses cell growth, telomerase activity and DNA repair in human breast cancer MCF-7 cells.
###end article-title 159
###begin article-title 160
EphrinA1 repulsive response is regulated by an EphA2 tyrosine phosphatase.
###end article-title 160
###begin article-title 161
Direct and biochemical interaction between dopamine D3 receptor and elongation factor-1Bbetagamma.
###end article-title 161
###begin article-title 162
eEF1B: At the dawn of the 21st century.
###end article-title 162
###begin article-title 163
###xml 0 5 <span type="species:ncbi:9606">Human</span>
Human arrest defective 1 acetylates and activates beta-catenin, promoting lung cancer cell proliferation.
###end article-title 163
###begin article-title 164
###xml 68 73 <span type="species:ncbi:9606">human</span>
Antiproliferative effects of cyclopentenyl cytosine (NSC 375575) in human glioblastoma cells.
###end article-title 164
###begin article-title 165
A molecular role for lysyl oxidase-like 2 enzyme in snail regulation and tumor progression.
###end article-title 165
###begin article-title 166
The potential role of the heparin-binding growth factor pleiotrophin in breast cancer.
###end article-title 166
###begin article-title 167
Inhibiting Ras signaling in the therapy of breast cancer.
###end article-title 167
###begin article-title 168
Inhibitors of Ras signal transduction as antitumor agents.
###end article-title 168
###begin article-title 169
The influence of MMP-14, TIMP-2 and MMP-2 expression on breast cancer prognosis.
###end article-title 169
###begin article-title 170
Histone deacetylase 3 represses p15(INK4b) and p21(WAF1/cip1) transcription by interacting with Sp1.
###end article-title 170
###begin article-title 171
Role of class I and class II histone deacetylases in carcinoma cells using siRNA.
###end article-title 171
###begin article-title 172
Anti-apoptotic signaling of pleiotrophin through its receptor, anaplastic lymphoma kinase.
###end article-title 172
###begin article-title 173
###xml 86 91 <span type="species:ncbi:9606">human</span>
Presence of activated ras correlates with increased cysteine proteinase activities in human colorectal carcinomas.
###end article-title 173
###begin article-title 174
###xml 54 59 <span type="species:ncbi:9606">human</span>
Bag1 proteins regulate growth and survival of ZR-75-1 human breast cancer cells.
###end article-title 174
###begin article-title 175
The lysosomal protease cathepsin L is an important regulator of keratinocyte and melanocyte differentiation during hair follicle morphogenesis and cycling.
###end article-title 175
###begin article-title 176
BNIPL-2, a novel homologue of BNIP-2, interacts with Bcl-2 and Cdc42GAP in apoptosis.
###end article-title 176
###begin article-title 177
Overexpression of KAI1 suppresses in vitro invasiveness and in vivo metastasis in breast cancer cells.
###end article-title 177
###begin article-title 178
KAI1/CD82, a tumor metastasis suppressor.
###end article-title 178
###begin article-title 179
###xml 78 83 <span type="species:ncbi:9606">human</span>
###xml 123 128 <span type="species:ncbi:9606">human</span>
Galectin-8 expression decreases in cancer compared with normal and dysplastic human colon tissue and acts significantly on human colon cancer cell migration as a suppressor.
###end article-title 179
###begin article-title 180
p16 inhibits matrix metalloproteinase-2 expression via suppression of Sp1-mediated gene transcription.
###end article-title 180
###begin article-title 181
Activation of EphA2 kinase suppresses integrin function and causes focal-adhesion-kinase dephosphorylation.
###end article-title 181
###begin article-title 182
The expression of integrin alpha(v)beta6 promotes the epithelial cell morphology and suppresses invasive behavior in transformed oral keratinocytes.
###end article-title 182
###begin article-title 183
PEA-15 Inhibits Tumor Cell Invasion by Binding to Extracellular Signal-Regulated Kinase 1/2.
###end article-title 183
###begin article-title 184
The clinicopathological and prognostic significance of membrane type 1 matrix metalloproteinase (MT1-MMP) and MMP-9 according to their localization in invasive breast carcinoma.
###end article-title 184
###begin article-title 185
Expression of MT-1 MMP, MMP2, MMP9 and TIMP2 mRNAs in ductal carcinoma in situ and invasive ductal carcinoma of the breast.
###end article-title 185
###begin article-title 186
###xml 29 34 <span type="species:ncbi:9606">human</span>
Role of ICAM1 in invasion of human breast cancer cells.
###end article-title 186
###begin article-title 187
###xml 82 87 <span type="species:ncbi:9606">human</span>
Chemokine (C-C motif) ligand 2 mediates the prometastatic effect of dysadherin in human breast cancer cells.
###end article-title 187
###begin article-title 188
The molecular portrait of in vitro growth by meta-analysis of gene-expression profiles.
###end article-title 188
###begin article-title 189
Role of CD44 in nonpalpable T1a and T1b breast cancer.
###end article-title 189
###begin article-title 190
Glycoprotein CD44 expression and its association with survival in breast cancer.
###end article-title 190
###begin article-title 191
CD44 stimulation down-regulates Fas expression and Fas-mediated apoptosis of lung cancer cells.
###end article-title 191
###begin article-title 192
Angiogenesis and cathepsin expression are prognostic factors in pancreatic adenocarcinoma after curative resection.
###end article-title 192
###begin article-title 193
Network biology: understanding the cell's functional organization.
###end article-title 193
###begin article-title 194
Network theory to understand microarray studies of complex diseases.
###end article-title 194
###begin article-title 195
Network-based classification of breast cancer metastasis.
###end article-title 195
###begin article-title 196
EGR2 mutations in inherited neuropathies dominant-negatively inhibit myelin gene expression.
###end article-title 196
###begin article-title 197
Novel activation of STAT5b in response to epidermal growth factor.
###end article-title 197
###begin article-title 198
Type I interferon differential therapy for erythroleukemia: specificity of STAT activation.
###end article-title 198
###begin article-title 199
Jaks and STATs: biological implications.
###end article-title 199
###begin article-title 200
The cytoplasmic tyrosine kinase Pyk2 as a novel effector of fibroblast growth factor receptor 3 activation.
###end article-title 200
###begin article-title 201
Transcriptional regulation of insulin-like growth factor-I by interferon-gamma requires STAT-5b.
###end article-title 201
###begin article-title 202
RAGE- and TGF-beta receptor-mediated signals converge on STAT5 and p21waf to control cell-cycle progression of mesangial cells: a possible role in the development and progression of diabetic nephropathy.
###end article-title 202
###begin article-title 203
Effects of tumor necrosis factor-alpha (TNF alpha) in epidermal keratinocytes revealed using global transcriptional profiling.
###end article-title 203
###begin article-title 204
###xml 98 103 <span type="species:ncbi:9606">human</span>
Divergent gene regulation and growth effects by NF-kappa B in epithelial and mesenchymal cells of human skin.
###end article-title 204
###begin article-title 205
Signal transducer and activator of transcription 5a influences mammary epithelial cell survival and tumorigenesis.
###end article-title 205
###begin article-title 206
###xml 66 81 <span type="species:ncbi:10090">transgenic mice</span>
Overexpression and forced activation of stat5 in mammary gland of transgenic mice promotes cellular proliferation, enhances differentiation, and delays postlactational apoptosis.
###end article-title 206
###begin article-title 207
Gene expression profiles of poor-prognosis primary breast cancer correlate with survival.
###end article-title 207
###begin article-title 208
Signal transducer and activator of transcription-5 activation and breast cancer prognosis.
###end article-title 208
###begin article-title 209
###xml 75 80 <span type="species:ncbi:9606">human</span>
Stat5 promotes homotypic adhesion and inhibits invasive characteristics of human breast cancer cells.
###end article-title 209
###begin article-title 210
Defining the role of prolactin as an invasion suppressor hormone in breast cancer cells.
###end article-title 210
###begin article-title 211
Stat5 in the mammary gland: controlling normal development and cancer.
###end article-title 211
###begin article-title 212
Stat5 activation inhibits prolactin-induced AP-1 activity: distinct prolactin-initiated signals in tumorigenesis dependent on cell context.
###end article-title 212
###begin article-title 213
###xml 80 85 <span type="species:ncbi:9606">human</span>
Stat5a is tyrosine phosphorylated and nuclear localized in a high proportion of human breast cancers.
###end article-title 213
###begin article-title 214
###xml 95 100 <span type="species:ncbi:9606">human</span>
Synergistic action of prolactin (PRL) and androgen on PRL-inducible protein gene expression in human breast cancer cells: a unique model for functional cooperation between signal transducer and activator of transcription-5 and androgen receptor.
###end article-title 214
###begin article-title 215
Co-expression and prognostic value of gross cystic disease fluid protein 15 and mammaglobin in primary breast cancer.
###end article-title 215
###begin article-title 216
Establishment and characterization of a new cell line (VHB-1) derived from a primary breast carcinoma.
###end article-title 216
###begin article-title 217
Towards standardization of RNA quality assessment using user-independent classifiers of microcapillary electrophoresis traces.
###end article-title 217
###begin article-title 218
The RIN: an RNA integrity number for assigning integrity values to RNA measurements.
###end article-title 218
###begin article-title 219
###xml 17 22 <span type="species:ncbi:9606">human</span>
Isolation from a human seminal vesicle library of the cDNA for gp17, a CD4 binding factor.
###end article-title 219
###begin article-title 220
###xml 50 55 <span type="species:ncbi:10090">mouse</span>
Comparison of three actin-coding sequences in the mouse; evolutionary relationships between the actin genes of warm-blooded vertebrates.
###end article-title 220
###begin article-title 221
Deciphering cellular states of innate tumor drug responses.
###end article-title 221
###begin article-title 222
Minimum information about a microarray experiment (MIAME)-toward standards for microarray data.
###end article-title 222
###begin article-title 223
Determination of minimum sample size and discriminatory expression patterns in microarray data.
###end article-title 223
###begin article-title 224
G*Power 3: a flexible statistical power analysis program for the social, behavioral, and biomedical sciences.
###end article-title 224
###begin article-title 225
Cluster analysis and display of genome-wide expression patterns.
###end article-title 225
###begin article-title 226
CIT: identification of differentially expressed clusters of genes from microarray data.
###end article-title 226
###begin article-title 227
Controlling the false discovery rate: a practical and powerful approach to multiple testing. .
###end article-title 227
###begin article-title 228
Significance analysis of microarrays applied to the ionizing radiation response.
###end article-title 228
###begin p 229
###xml 0 21 0 21 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Competing Interests: </bold>
Competing Interests: The authors have declared that no competing interests exist.
###end p 229
###begin p 230
###xml 0 9 0 9 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Funding: </bold>
Funding: This work was supported by the Centre National de la Recherche Scientifique (CNRS) and by grants from Association pour la Recherche sur le Cancer (ARC) to D.P.T.. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
###end p 230

